var title_f1_33_1552="Anti GBM disease IF";
var content_f1_33_1552=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F63060&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F63060&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Immunofluorescence microscopy showing linear IgG",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 395px; height: 256px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Immunofluorescence microscopy showing characteristic linear deposition of IgG in anti-GBM antibody disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Helmut Rennke, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1552=[""].join("\n");
var outline_f1_33_1552=null;
var title_f1_33_1553="Mutations integr inhibitors";
var content_f1_33_1553=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F54130&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F54130&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 629px\">",
"   <div class=\"ttl\">",
"    Mutations in the integrase gene associated with resistance to integrase inhibitors",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 609px; height: 203px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted with permission from: the International AIDS Society-USA. Johnson VA, Brun-V&eacute;zinet F, Clotet B, G&uuml;nthard HF, Kuritzkes DR, Pillay D, Schapiro JM, and Richman DD. Update of the Drug Resistance Mutations in HIV-1: December 2010. Topics in HIV Medicine 2010; 18(5):156-163. Updated information (and thorough explanatory notes) are available at",
"     <a href=\"file://www.iasusa.org\" target=\"_blank\">",
"      www.iasusa.org",
"     </a>",
"     .",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1553=[""].join("\n");
var outline_f1_33_1553=null;
var title_f1_33_1554="T PLL blood smear";
var content_f1_33_1554=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F64572&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F64572&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 536px\">",
"   <div class=\"ttl\">",
"    T cell prolymphocytic leukemia",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 516px; height: 231px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Blood smear from a patient with T cell prolymphocytic leukemia. The tumor cells are medium-sized lymphoid cells with moderately condensed chromatin and a prominent nucleolus. In T-PLL, the nucleus can be round or oval and the cytoplasm is slightly basophilic without granules. Cytoplasmic protrusions (blebs) are common.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Kindly provided by Sarayu Chandrashekhar, MD, Department of Pathology, Beth Israel Deaconess Medical Center, Boston, MA.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1554=[""].join("\n");
var outline_f1_33_1554=null;
var title_f1_33_1555="Histology lung 1";
var content_f1_33_1555=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F78977&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F78977&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Histology lung 1",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 366px; height: 240px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1555=[""].join("\n");
var outline_f1_33_1555=null;
var title_f1_33_1556="Travelers' diarrhea and cholera vaccine: Patient drug information";
var content_f1_33_1556=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Travelers' diarrhea and cholera vaccine: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/10/15525?source=see_link\">",
"     see \"Travelers' diarrhea and cholera vaccine: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F3274459\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Dukoral&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10012592\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691568",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to stop travelers' diarrhea and cholera.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10012591\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703064",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to travelers' diarrhea and cholera vaccine or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a latex allergy, talk with your doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10012596\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697668",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug does not give 100% protection. You must still follow steps to protect the body from travelers' diarrhea and cholera. Talk with the doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10012597\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696437",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       All bad side effects to this vaccine must be reported to the Senior Product Safety Officer, Aventis Pasteur Limited. Ask your doctor to file the report. You may also call to file a report at 1-888-621-1146.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698328",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Unsafe allergic effects may rarely happen.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10012599\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699008",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10012594\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2749850",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take on an empty stomach. Take 1 hour before or 1 hour after meals.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694659",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Melt 1 packet in 5 ounces of water.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2749825",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not mix with juice, milk, or other drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695633",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Shake vaccine liquid and add to the mixture. Mix well and drink.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695942",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take the last dose at least 1 week before you travel to the high risk place.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10012600\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699391",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a refrigerator. Do not freeze.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2749830",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       After mixing, you may store at room temperature for 2 hours.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699173",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Drink within 2 hours of mixing.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10012601\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11890 Version 31.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1005-122.72.76.133-425BDFC11D-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1556=[""].join("\n");
var outline_f1_33_1556=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F3274459\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012592\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012591\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012596\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012597\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012599\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012594\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012600\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10012601\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?15/10/15525?source=related_link\">",
"      Travelers' diarrhea and cholera vaccine: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_33_1557="ECG_Left lateral WPW III";
var content_f1_33_1557=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F59047&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F59047&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    12-lead electrocardiogram (ECG) showing a left lateral atrioventricular accessory pathway in a patient with Wolff-Parkinson-White (WPW) syndrome",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 390px; height: 246px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram during sinus rhythm from a patient with a left lateral accessory pathway. Panel A: Normal PR interval and a fairly normal QRS complex. Panel B: With pacing from the coronary sinus at a site close to the accessory pathway, the QRS complexes are maximally preexcited.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1557=[""].join("\n");
var outline_f1_33_1557=null;
var title_f1_33_1558="Pathogenesis and diagnosis of viral arthritis";
var content_f1_33_1558=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Pathogenesis and diagnosis of viral arthritis",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/33/1558/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/33/1558/contributors\">",
"     Terry L Moore, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/33/1558/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/33/1558/contributors\">",
"     Peter H Schur, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/33/1558/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/33/1558/contributors\">",
"     Paul L Romain, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/33/1558/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Aug 22, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Arthritis and arthralgias are well-recognized and relatively common accompaniments to viral infections. The most common viruses causing arthritis and arthralgias are parvovirus, hepatitis B, hepatitis C, rubella, and the alphaviruses [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/1\">",
"     1",
"    </a>",
"    ]. Joint complaints are also observed less commonly in association with a wide variety of other viral infections (eg, mumps, enteroviruses, herpesviruses) (",
"    <a class=\"graphic graphic_table graphicRef73403 \" href=\"UTD.htm?15/52/16203\">",
"     table 1",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    This topic will provide a general overview of the pathophysiology, presentation, diagnosis, and treatment of viral arthritis. Specific viruses that cause arthritis are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23354?source=see_link\">",
"     \"Specific viruses that cause arthritis\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;No virus has been implicated as a cause of the common forms of chronic inflammatory arthritis such as rheumatoid arthritis or systemic lupus erythematosus. However, viruses are able to initiate rheumatic symptoms via a variety of different mechanisms. Viruses may cause effects through numerous mechanisms that depend on host factors, including age, gender, genetics, infectious history, and immune response [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/1-5\">",
"     1-5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Direct invasion",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viruses may directly invade the joint, resulting in infection of the synovium or other joint tissues. This may be the mechanism utilized by rubella and rubella vaccine virus despite the fact that viral isolation from a joint is a rare occurrence [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/6-11\">",
"     6-11",
"    </a>",
"    ]. In vivo data support the tropism of these viruses for synovial tissue and their potential for both lytic and persistent infection. Other viruses that may be arthrotropic include parvoviruses [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/12\">",
"     12",
"    </a>",
"    ] and enteroviruses [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/13\">",
"     13",
"    </a>",
"    ]; both of these have been successfully isolated from joint fluid.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Immune complex formation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral particles (either whole virions or viral antigens) may act as the antigenic component of immune complexes formed by the humoral response to viral infection [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/1,2,12,14\">",
"     1,2,12,14",
"    </a>",
"    ]. These immune complexes may be preferentially deposited in the joints and skin, leading to arthralgias, arthritis, and rash. This type of presentation is common and has been well-documented in the cases of hepatitis B infection, alphaviruses, hepatitis C (often via the formation of cryoglobulins), and parvovirus. Antibodies directed against viral antigens also may crossreact with tissue antigens, a process called molecular mimicry [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/3,4\">",
"     3,4",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Latent viruses and immune dysregulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viruses may establish persistent infections in which the host cells remain metabolically active, expressing viral antigens on their cell surfaces [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/15,16\">",
"     15,16",
"    </a>",
"    ]. These antigens become a target for the immune system, resulting in the development of chronic inflammatory reactions. This situation has not been documented to occur in synovial tissues in man but has been seen with lentivirus infection in animals in which it gives rise to a chronic form of caprine arthritis [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/17\">",
"     17",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Viruses may also directly infect elements of the immune system [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/18\">",
"     18",
"    </a>",
"    ]. This can lead to a primary immunologic derangement, which could eventually produce signs or symptoms of autoimmunity and rheumatic disease.",
"   </p>",
"   <p>",
"    Also, in many patients with autoimmune disease, a potential complication of immunosuppressive therapy is reactivation of pathogenic viruses that have remained latent. The most commonly encountered are varicella-zoster virus, hepatitis B and C, Epstein-Barr virus, and polyoma JC virus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/19\">",
"     19",
"    </a>",
"    ]. Many cases of reactivation of Epstein-Barr infections have been seen in patients with rheumatoid arthritis or juvenile idiopathic arthritis on biologics such as the TNF inhibitors or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?40/12/41161?source=see_link\">",
"     rituximab",
"    </a>",
"    .",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL PRESENTATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Patients with viral arthritis tend to present with symmetric polyarticular disease that may consist of arthralgias alone or a true arthritis that can mimic a rheumatic disease. In general, the musculoskeletal signs and symptoms are seen during the prodrome of, or coincident with, the clinical onset of infection. Joint involvement tends to be of sudden onset and of relatively short duration and may be accompanied by a rash.",
"   </p>",
"   <p>",
"    Arthralgias and arthritis generally do not persist or recur in the vast majority of cases of viral arthritis. Exceptions to this rule have been reported with infections due to rubella virus, parvovirus, and alphavirus [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/9-12\">",
"     9-12",
"    </a>",
"    ]. Even in instances of persistent or recurrent symptoms, however, viral arthritis has not been shown to lead to persistent chronic arthritis and destructive joint disease.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Establishing or even suspecting the diagnosis of viral arthritis varies with the clinical setting. In some patients, the diagnosis may be strongly suspected on clinical grounds because of a classic rash (rubella), facial rash (parvovirus), physical finding (parotid enlargement in mumps or jaundice in hepatitis B or hepatitis C virus infection), or historical feature (onset after rubella vaccination). In many cases, however, the diagnosis of viral arthritis is made difficult by the following features:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is no single presentation that is typical of viral arthritides.",
"     </li>",
"     <li>",
"      Many of the signs and symptoms are general in nature (fever, arthralgia, rash) and can be seen in several different types of disorders.",
"     </li>",
"     <li>",
"      Arthritis may occur before the onset of the major signs of the viral infection (eg, before icterus in hepatitis B virus infection).",
"     </li>",
"     <li>",
"      Evidence of viral infection (viral isolation or serologic evidence of recent infection) is difficult to document.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    As a result, there are two components to the diagnostic approach to viral arthritis: establishing the diagnosis when it is suspected (which usually begins with serologic testing), and evaluating the patient with polyarticular joint pain when a specific viral infection is not suspected.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Serology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Serologic testing is the most common means of establishing a viral etiology for a clinical condition. Serologic diagnosis is based upon two facets of the immune system&rsquo;s response to viral infections: the first exposure to an agent results in the development of an initial IgM response, and the IgM response is followed by isotype switching and by the appearance of IgG antibodies. Thus, if viral infection is suspected, serum should be collected immediately and then approximately two to three weeks later. Serologic testing must be directed against the specific viruses suspected to be involved based upon both epidemiologic and clinical data.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An acute IgM antibody response followed by the presence of IgG antibodies against the suspected agent confirms a viral etiology.",
"     </li>",
"     <li>",
"      A significant (greater than fourfold) time-related increase in IgG also suggests a recent infection in which the initial sample was obtained too late to detect the IgM response. Alternatively, this serologic pattern could represent reinfection with a particular virus or recrudescence of infection.",
"     </li>",
"     <li>",
"      The presence of a stable level of IgG antibody is not diagnostic of recent infection since it may represent a viral infection that significantly antedated the onset of arthritis.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Immunoassays for both IgM and IgG antibodies to a variety of viral components have replaced the older classical means of serologic diagnosis. Direct testing of serum for viral-specific nucleic acid by polymerase chain reaction (PCR) can also be performed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Viral isolation from the joint",
"    </span>",
"    &nbsp;&mdash;&nbsp;Strict confirmation of a viral etiology of an arthritic condition requires isolation of the etiologic agent from the site of musculoskeletal symptoms (joint fluid or synovium). Any isolate from the joint can be considered pathogenic since the joint does not harbor known persistent viruses. Care must be exercised, however, not to culture blood elements as a consequence of a traumatic aspiration or as part of the synovial material that is biopsied. Synovial biopsy for possible viral isolation should be performed in clinical practice in patients with persistent synovitis of unknown etiology that has not responded to medical therapy.",
"   </p>",
"   <p>",
"    The following viruses have been isolated from joint fluid or synovium in individuals with clinical signs of arthritis: rubella virus, rubella vaccine virus, parvovirus, enterovirus, vaccinia virus, and herpes family viruses [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/1,11,17\">",
"     1,11,17",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23354?source=see_link\">",
"     \"Specific viruses that cause arthritis\"",
"    </a>",
"    .) In addition to isolation of the virus, identification of viral nucleic acid by PCR is another method to confirm viral infection of the joint. PCR may be helpful in selected cases but is difficult to use as a screening tool.",
"   </p>",
"   <p>",
"    However, only a small number of viruses directly infect the joint, and viral isolation in these cases is accomplished infrequently. Thus, other means must be employed to make the diagnosis of viral arthritis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Viral isolation from other tissues",
"    </span>",
"    &nbsp;&mdash;&nbsp;Viral cultures from other parts of the body can be attempted. For cases in which viral isolation is unequivocally pathogenic (eg, rubella and arthropod-borne alphaviruses), identification of the virus represents strong presumptive evidence for the etiology of the associated joint symptoms. In contrast, one cannot unequivocally relate joint symptoms with the isolation of commonly found organisms (eg, enteroviruses from the stool or Epstein-Barr virus from the blood or saliva). In clinical practice, this would only be performed in patients with persistently active disease of unknown etiology despite other testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Other laboratory tests",
"    </span>",
"    &nbsp;&mdash;&nbsp;Other laboratory tests have been of little value in differentiating viral arthritis from other musculoskeletal conditions.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      There is usually little change in the white blood cell count, although some viral infections are associated with either a mild leukocytosis or lymphopenia.",
"     </li>",
"     <li>",
"      Liver function tests may be elevated with infections due to viruses that have tropism for the liver (eg, hepatitis B and C viruses, parvovirus, and Epstein-Barr virus).",
"     </li>",
"     <li>",
"      Complement levels are not of diagnostic utility, although low levels may be seen with immune complex deposition diseases. Essential mixed cryoglobulinemia, which is associated with both arthritis and hypocomplementemia, is most often due to hepatitis C virus infection. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34040?source=see_link\">",
"       \"Clinical manifestations and diagnosis of the mixed cryoglobulinemia syndrome (essential mixed cryoglobulinemia)\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Detection of viral DNA in synovium or synovial fluid is an attractive approach in theory, but, in practice, high rates of detection of viral DNA sequences in controls (eg, 50 percent and 21 percent for parvovirus B19 in synovium and synovial fluid, respectively, of controls with osteoarthritis [",
"      <a class=\"abstract\" href=\"UTD.htm?1/33/1558/abstract/20\">",
"       20",
"      </a>",
"      ]) have limited usefulness of PCR in clinical practice.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Synovial fluid analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Evaluation of synovial fluid is of limited utility in the diagnosis of viral arthritis except for the occasional positive culture. The synovial leukocyte counts may be elevated, occasionally to quite high levels; however, normal cell counts are not uncommon. There may be a predominance of polymorphonuclear leukocytes or lymphocytes, depending upon the viral etiology. Most importantly, the synovial fluid should always be cultured for bacteria and other organisms as well as viruses, in order to detect a potentially treatable disorder.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Approach to the patient with polyarticular joint pain",
"    </span>",
"    &nbsp;&mdash;&nbsp;The patient in whom there is no obvious association with a particular viral infection must be evaluated for the multiple other causes of polyarticular joint pain (",
"    <a class=\"graphic graphic_table graphicRef74266 \" href=\"UTD.htm?31/60/32716\">",
"     table 2",
"    </a>",
"    ). This topic is discussed in detail separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34039?source=see_link\">",
"     \"Evaluation of the adult with polyarticular pain\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A possible viral etiology should be considered in patients with synovitis of less than six weeks&rsquo; duration and in those with polyarthralgias without synovitis. Complete blood count (CBC), urinalysis, erythrocyte sedimentation rate, C-reactive protein, and comprehensive metabolic panel including liver function tests and muscle enzymes should be obtained in all such patients, along with testing for rheumatoid factor, anticyclic citrullinated peptide antibodies, and antinuclear antibody profiles to help rule out rheumatoid arthritis or a systemic rheumatic disease. Serologic testing for hepatitis B and C virus, parvovirus, and Epstein-Barr virus infection should be considered in any child or adult patient in whom the etiology of their synovitis is unclear despite initial routine testing.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Therapy in viral arthritis is generally directed at relief of symptoms and at maintenance of function. Patients should be treated with analgesic agents (eg,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"     acetaminophen",
"    </a>",
"    ) and nonsteroidal antiinflammatory drugs in doses typically used in any inflammatory arthropathy. Physical and occupational therapy can be initiated if required to maintain or improve function.",
"   </p>",
"   <p>",
"    The use of glucocorticoids, either orally or by intraarticular injection, should be discouraged since they are of limited utility in this disorder. Use of glucocorticoids may mask the disease and the correct diagnosis.",
"   </p>",
"   <p>",
"    There is no need for specific antiviral therapy since most viral arthritides are of short duration and are self-limited. This is fortunate because no specific antiviral therapy exists for most of the agents implicated in causing rheumatic disease. One exception is interferon-alpha for hepatitis C virus-induced mixed cryoglobulinemia. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/52/36682?source=see_link\">",
"     \"Treatment of the mixed cryoglobulinemia syndrome\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32747380\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The most common viruses causing arthritis and arthralgias are parvovirus, hepatitis B, hepatitis C, rubella, and the alphaviruses, as well as Epstein-Barr virus infections in patients on biologics. Joint complaints are also observed less commonly in association with a wide variety of other viral infections (eg, mumps, enteroviruses, herpesviruses) (",
"      <a class=\"graphic graphic_table graphicRef73403 \" href=\"UTD.htm?15/52/16203\">",
"       table 1",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Viruses are able to initiate rheumatic symptoms via a variety of different mechanisms that depend upon host factors, including age, gender, genetics, infectious history, and immune response. Major mechanisms include the direct invasion of the joint (eg, rubella and enteroviruses) and immune complex formation, which may occur both in the joints and in the skin (eg, hepatitis B and C, alphaviruses). Parvovirus may use both of these mechanisms. Molecular mimicry may also occur. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Pathophysiology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H3\">",
"       'Direct invasion'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'Immune complex formation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The usual presentation includes the sudden onset of symmetric polyarticular arthralgias or arthritis, sometimes associated with a rash. The musculoskeletal manifestations are typically seen during the prodrome of, or coincident with, the clinical onset of infection. Articular manifestations generally do not persist or recur, except with infections due to rubella virus, parvovirus, and alphavirus. Viral arthritis has not been shown to lead to persistent chronic arthritis and destructive joint disease even when symptoms persist or recur. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical presentation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The two components to the diagnostic approach to viral arthritis are establishing the diagnosis when it is suspected (which usually begins with serologic testing) and evaluating the patient with polyarticular joint pain when a specific viral infection is not suspected. Signs and symptoms are usually nonspecific, and clinical evidence of a specific viral etiology on exam may occur but is uncommon. Thus, if viral infection is suspected, serum should be collected immediately and then approximately two to three weeks later to detect the IgM antibody response seen with exposure to the agent and the switch to an increasing IgG response. Serologic testing must be directed against the specific viruses suspected to be involved based upon both epidemiologic and clinical data. Other laboratory tests have been of little value in differentiating viral arthritis from other musculoskeletal conditions. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Serology'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H11\">",
"       'Other laboratory tests'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      We consider a possible viral etiology in patients with synovitis of less than six weeks&rsquo; duration and in those with polyarthralgias without synovitis. Our initial evaluation in all such patients includes a complete blood count (CBC), urinalysis, erythrocyte sedimentation rate, C-reactive protein, and comprehensive metabolic panel including liver function tests and muscle enzymes. Serologic testing for hepatitis B and C virus, parvovirus, and Epstein-Barr virus infection should be performed in any child or adult patient if the etiology is not established with routine testing. Testing for rheumatoid factor, anticyclic citrullinated peptide antibodies, and antinuclear antibodies should be performed to rule out rheumatoid arthritis or a systemic rheumatic disease. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Approach to the patient with polyarticular joint pain'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Therapy is generally directed at relief of symptoms and at maintenance of function by use of analgesic agents (eg,",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      ) and nonsteroidal antiinflammatory drugs in antiinflammatory doses; physical and occupational therapy can be initiated if required to maintain or improve function. We generally avoid the use of either oral or intraarticular glucocorticoids. (See",
"      <a class=\"local\" href=\"#H14\">",
"       'Treatment'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Naides SJ, Schnitzer TJ. Viral arthritis. In: Textbook of Rheumatology, Kelley WN, Harris ED, Budd RC, et al (Eds), WB Saunders, Phildelphia 2005.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/2\">",
"      Pennisi E. Genes, junctions, and disease at cell biology meeting. Science 1996; 274:2008.",
"     </a>",
"    </li>",
"    <li>",
"     Oldstone MBA, Notkins AL. Molecular mimicry. In: Concepts in Viral Pathogenesis II, Notkins AL, Oldstone MBA (Eds), Springer-Verlag, New York 1986.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/4\">",
"      Albert LJ, Inman RD. Molecular mimicry and autoimmunity. N Engl J Med 1999; 341:2068.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/5\">",
"      Ramos-Casals M. Viruses and lupus: the viral hypothesis. Lupus 2008; 17:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/6\">",
"      Ogra PL, Herd JK. Arthritis associated with induced rubella infection. J Immunol 1971; 107:810.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/7\">",
"      Chantler JK, Tingle AJ, Petty RE. Persistent rubella virus infection associated with chronic arthritis in children. N Engl J Med 1985; 313:1117.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/8\">",
"      Fraser JR, Cunningham AL, Hayes K, et al. Rubella arthritis in adults. Isolation of virus, cytology and other aspects of the synovial reaction. Clin Exp Rheumatol 1983; 1:287.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/9\">",
"      Ford DK, da Roza DM, Reid GD, et al. Synovial mononuclear cell responses to rubella antigen in rheumatoid arthritis and unexplained persistent knee arthritis. J Rheumatol 1982; 9:420.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/10\">",
"      Weibel RE, Stokes J Jr, Buynak EB, Hilleman MR. Rubella vaccination in adult females. N Engl J Med 1969; 280:682.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/11\">",
"      Chantler JK, da Roza DM, Bonnie ME, et al. Sequential studies on synovial lymphocyte stimulation by rubella antigen, and rubella virus isolation in an adult with persistent arthritis. Ann Rheum Dis 1985; 44:564.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/12\">",
"      Moore TL. Parvovirus-associated arthritis. Curr Opin Rheumatol 2000; 12:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/13\">",
"      Kujala G, Newman JH. Isolation of echovirus type 11 from synovial fluid in acute monocytic arthritis. Arthritis Rheum 1985; 28:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/14\">",
"      Casali P, Oldstone MB. Immune complexes in viral infection. Curr Top Microbiol Immunol 1983; 104:7.",
"     </a>",
"    </li>",
"    <li>",
"     Oldstone MBA. The role of cytotoxic T lymphocytes in infectious disease: History, criteria, and state of the art. In: Current Topics in Microbiology and Immunology, Oldstone MBA (Ed), Springer-Verlag, Berlin 1994.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/16\">",
"      Oldstone MB. Viral persistence. Cell 1989; 56:517.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/17\">",
"      Michaels FH, Banks KL, Reitz MS Jr. Lessons from caprine and ovine retrovirus infections. Rheum Dis Clin North Am 1991; 17:5.",
"     </a>",
"    </li>",
"    <li>",
"     Rott IM. Immunity to viral infection. In: Essential Immunology, 10th, Rott IM, Delves PJ (Eds), Blackwell Science Ltd, Oxford 2001.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/19\">",
"      Chakravarty EF. Viral infection and reactivation in autoimmune disease. Arthritis Rheum 2008; 58:2949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1558/abstract/20\">",
"      Peterlana D, Puccetti A, Beri R, et al. The presence of parvovirus B19 VP and NS1 genes in the synovium is not correlated with rheumatoid arthritis. J Rheumatol 2003; 30:1907.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5614 Version 4.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.81.197.98-D795AC79FE-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1558=[""].join("\n");
var outline_f1_33_1558=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H32747380\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Direct invasion",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Immune complex formation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Latent viruses and immune dysregulation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL PRESENTATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Serology",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Viral isolation from the joint",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Viral isolation from other tissues",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Other laboratory tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Synovial fluid analysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Approach to the patient with polyarticular joint pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H32747380\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"RHEUM/5614\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"RHEUM/5614|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?15/52/16203\" title=\"table 1\">",
"      Viruses and polyarthralgias",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/60/32716\" title=\"table 2\">",
"      Causes polyarticular joint pain",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34040?source=related_link\">",
"      Clinical manifestations and diagnosis of the mixed cryoglobulinemia syndrome (essential mixed cryoglobulinemia)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/15/34039?source=related_link\">",
"      Evaluation of the adult with polyarticular pain",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/51/23354?source=related_link\">",
"      Specific viruses that cause arthritis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/52/36682?source=related_link\">",
"      Treatment of the mixed cryoglobulinemia syndrome",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_33_1559="Aortic regurgitation in children";
var content_f1_33_1559=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Aortic regurgitation in children",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/33/1559/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/33/1559/contributors\">",
"     David W Brown, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/33/1559/contributors\">",
"     John F Keane, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/33/1559/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/33/1559/contributors\">",
"     David R Fulton, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/33/1559/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/33/1559/contributors\">",
"     Melanie S Kim, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/33/1559/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 15, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortic regurgitation (AR) is a common finding in children undergoing echocardiography. It rarely occurs as an isolated lesion, as it is usually associated with aortic stenosis (AS) or a ventricular septal defect (VSD). The latter disorders are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/28/38345?source=see_link\">",
"     \"Valvar aortic stenosis in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=see_link\">",
"     \"Pathophysiology and clinical features of isolated ventricular septal defects in infants and children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     PHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;All forms of AR produce a similar hemodynamic abnormality. The inability of the aortic valve leaflets to remain closed during diastole results in a portion of the left ventricular stroke volume leaking back from the aorta into the left ventricle. The added volume of regurgitant blood produces an increase in left ventricular end-diastolic volume; according to Laplace's law, the increase in left ventricular end-diastolic volume causes an elevation in wall stress. The heart responds with compensatory myocardial hypertrophy, which returns wall stress toward normal [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The combination of hypertrophy and chamber enlargement raises the total stroke volume. The net effect is that forward stroke volume and therefore cardiac output are initially maintained despite the regurgitant lesion. Although the left ventricular volume is increased, end-diastolic pressure is normal due to an increase in ventricular compliance. Thus, the heart initially adapts well to chronic aortic regurgitation, functioning as a very efficient and compliant high output pump.",
"   </p>",
"   <p>",
"    Severe AR results in increased end-systolic and end-diastolic volumes and decreased function [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/1\">",
"     1",
"    </a>",
"    ]. Reduced aortic diastolic pressures from excessive runoff, especially during exercise, may impair coronary perfusion, while increased left atrial pressure may lead to pulmonary edema. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38039?source=see_link\">",
"     \"Pathophysiology, clinical features, and evaluation of chronic aortic regurgitation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     ETIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are many etiologies of AR, which rarely occurs as an isolated lesion [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/2\">",
"     2",
"    </a>",
"    ]. A bicuspid aortic valve is a common cause. AR also occurs in children with Marfan syndrome but, as described below, is more common in adults in association with progressive aortic root dilation. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/3/20538?source=see_link\">",
"     \"Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders\"",
"    </a>",
"    .) Rheumatic heart disease was an important etiology in the past, but is now uncommon in developed countries. Other associations include Turner syndrome, osteogenesis imperfecta, subaortic stenosis, prolapse of a leaflet through a VSD, tetralogy of Fallot, and truncus arteriosus.",
"   </p>",
"   <p>",
"    AR may be an acquired lesion, following an episode of infectious endocarditis or intervention for AS such as surgical or balloon valvuloplasty. Among patients with congenital valvar AS who are treated with balloon valvuloplasty, most have new or increased AR which, in one report, was moderate to severe in 13 percent after the procedure and in 38 percent at almost four years [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/3\">",
"     3",
"    </a>",
"    ]. The risk is increased in patients undergoing repeat balloon valvuloplasty. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/28/38345?source=see_link&amp;anchor=H18#H18\">",
"     \"Valvar aortic stenosis in children\", section on 'Balloon valvotomy'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PHYSICAL EXAMINATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The physical examination in children with AR is often subtle because most have mild disease; in addition, some of the classic findings in adults are seldom found in children even with moderate to severe AR. Nevertheless, it is useful to review the classic findings that are seen in more severe disease because they can often establish the clinical diagnosis.",
"   </p>",
"   <p>",
"    Both examination of the peripheral pulses and auscultation of the heart are particularly important. The increased stroke volume results in abrupt distension of the peripheral arteries and an elevation in systolic pressure. Regurgitation back into the left ventricle then leads to a rapid decline in pressure with quick collapse of the arteries and a low diastolic pressure that can fall below 30 mmHg in severe disease.",
"   </p>",
"   <p>",
"    The net effect is a wide pulse pressure, which is manifested on examination as a \"water hammer\" or Corrigan pulse. This finding may be best appreciated by palpation of the radial or brachial arteries (exaggerated by raising the arm) or the carotid pulses. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33013?source=see_link&amp;anchor=H13#H13\">",
"     \"Examination of the arterial pulse\", section on 'Water hammer pulse'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Other findings are associated with a hyperdynamic pulse:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      deMusset's sign &mdash; A head bob occurring with each heart beat.",
"     </li>",
"     <li>",
"      Traube's sign &mdash; A pistol shot pulse (systolic and diastolic sounds) heard over the femoral arteries.",
"     </li>",
"     <li>",
"      Duroziez's sign &mdash; A systolic and diastolic bruit heard when the femoral artery is partially compressed.",
"     </li>",
"     <li>",
"      Quincke's pulses &mdash; Capillary pulsations in the fingertips or lips.",
"     </li>",
"     <li>",
"      Mueller's sign &mdash; Systolic pulsations of the uvula.",
"     </li>",
"     <li>",
"      Becker's sign &mdash; Visible pulsations of the retinal arteries and pupils.",
"     </li>",
"     <li>",
"      Hill's sign &mdash; Popliteal cuff systolic pressure exceeding brachial pressure by more than 60 mmHg.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Exaggerated or bounding pulses and these physical signs are not specific for AR, since they can be seen in any condition associated with a marked increase in stroke volume, other aortic runoff lesions, or a hyperdynamic circulation. Causes of a hyperdynamic circulation include anemia, fever, thyrotoxicosis, large arteriovenous fistula, patent ductus arteriosus, and severe bradycardia.",
"   </p>",
"   <p>",
"    The combination of left ventricular enlargement and forceful systolic function results in the apical impulse being displaced laterally and inferiorly and being diffuse and hyperdynamic. A prominent pulsation (and occasionally a thrill) may be felt at the sternal notch due to concurrent dilatation of the ascending aorta.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Cardiac auscultation",
"    </span>",
"    &nbsp;&mdash;&nbsp;Chronic AR is associated with changes in the heart sounds and a distinctive murmur. The heart sounds typically have the following characteristics. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link\">",
"     \"Auscultation of cardiac murmurs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=see_link\">",
"     \"Auscultation of heart sounds\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      S1 may be soft, often reflecting a long PR interval",
"     </li>",
"     <li>",
"      S2 is variable; it may be soft, absent, or single",
"     </li>",
"     <li>",
"      A2 is often soft or absent while P2 may be normal, but obscured by the diastolic murmur",
"     </li>",
"     <li>",
"      A systolic ejection sound may be due to abrupt aortic distension caused by the large stroke volume",
"     </li>",
"     <li>",
"      A third heart sound (S3 gallop) is heard when left ventricular function is severely depressed",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Mild or more aortic regurgitation is invariably accompanied by a diastolic murmur. In a review of the literature, the presence of an early diastolic murmur, as heard by a cardiologist, was the most useful finding for establishing the presence of AR [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The diastolic murmur of aortic regurgitation begins immediately after A2 (",
"    <a class=\"graphic graphic_movie graphicRef77962 \" href=\"UTD.htm?0/12/195\">",
"     movie 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef76340 \" href=\"UTD.htm?39/27/40368\">",
"     movie 2",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef56371 \" href=\"UTD.htm?41/61/42960\">",
"     movie 3",
"    </a>",
"    ). It is high pitched, often blowing in quality, and may be sustained in intensity or decrescendo. It may be soft and barely audible, often appreciated only when the patient is sitting up, leaning forward, and holding his or her breath in expiration.",
"   </p>",
"   <p>",
"    The intensity of the murmur does not correlate well with the severity of AR. However, the timing and duration of the murmur may be helpful.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In mild aortic regurgitation, the murmur occurs only in early diastole and is blowing.",
"     </li>",
"     <li>",
"      As the regurgitation becomes more severe, the murmur extends through more of diastole, may become holodiastolic, and is often rougher in quality.",
"     </li>",
"     <li>",
"      In very severe regurgitation with ventricular decompensation, the murmur may become soft or even absent. This change in character reflects the near equivalence of aortic diastolic and left ventricular end-diastolic pressures which markedly diminishes regurgitant flow. A similar situation can occur when AR is acute and the left ventricular end-diastolic pressure is very high.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The site at which the murmur is best heard varies with the cause. The murmur is heard best along the left sternal border, at the third and fourth intercostal space, when aortic regurgitation is due to valvular disease. In contrast, abnormalities of the aortic root produce murmurs that are best heard at the right sternal border and apex.",
"   </p>",
"   <p>",
"    A systolic murmur can be heard in many patients. It typically resembles the ejection type of murmur heard in aortic stenosis, ie, a crescendo-decrescendo harsh murmur beginning after S1. This murmur does not necessarily reflect concurrent aortic stenosis, since the increased ejection rate and large stroke volume across the aortic valve can lead to a \"functional\" stenosis. However, as noted above, AR often occurs in association with other cardiac lesions that produce a systolic murmur, such as bicuspid aortic stenosis and VSD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/28/38345?source=see_link\">",
"     \"Valvar aortic stenosis in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A second type of diastolic murmur (the Austin Flint murmur) may also be appreciated. This murmur is a mid to late diastolic rumble, heard at the apex. It is the result of antegrade turbulent diastolic blood flow from the left atrium competing with the retrograde regurgitant flow from the aorta, the latter impinges upon the anterior mitral valve leaflet opening, causing some functional stenosis. The murmur may be confused with that of mitral stenosis. Distinguishing features from mitral stenosis include the absence of both a loud S1 and an opening snap of the mitral valve. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=see_link\">",
"     \"Auscultation of cardiac murmurs\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=see_link\">",
"     \"Auscultation of heart sounds\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Echocardiography is used to evaluate the degree of regurgitation and the anatomy of the lesion and any accompanying disorders and to assess ventricular function (",
"    <a class=\"graphic graphic_table graphicRef75256 \" href=\"UTD.htm?6/52/6989\">",
"     table 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef70063 \" href=\"UTD.htm?25/7/25716\">",
"     movie 4",
"    </a>",
"    and",
"    <a class=\"graphic graphic_figure graphicRef53257 \" href=\"UTD.htm?37/25/38288\">",
"     figure 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_movie graphicRef54254 \" href=\"UTD.htm?8/2/8227\">",
"     movie 5",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    Serial echocardiographic assessments are used to guide management. They can also help determine the timing of aortic valve surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other noninvasive tests reveal abnormalities but provide only adjunctive additional information to echocardiography. The chest radiograph is often remarkable for a prominent ascending aorta. An enlarged left ventricle may be seen with significant regurgitation. With moderate or greater regurgitation, the ECG frequently reveals LV hypertrophy and, with advanced disease, ST-T changes due to ischemia. Cardiac catheterization is usually unnecessary. It is used only to evaluate associated lesions.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     CLINICAL COURSE",
"    </span>",
"    &nbsp;&mdash;&nbsp;Few studies are available on the clinical course of AR. Most cases of AR are mild, symptoms are unusual, and the patient remains stable for many years. Progression occurs in some patients, while infective endocarditis may cause acute progression.",
"   </p>",
"   <p>",
"    The natural history of isolated congenital AR was described in seven children who did not have Marfan syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/2\">",
"     2",
"    </a>",
"    ]. The diagnosis was made in infancy in five. Three patients were asymptomatic through follow-up at 8, 10, and 20 years, while four required valve replacement at age 3, 10, 15, and 20 years for progressive severity.",
"   </p>",
"   <p>",
"    Dilatation of the aorta is common in children with Marfan syndrome and progresses with time. One report followed 52 patients with Marfan syndrome through childhood and adolescence [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/6\">",
"     6",
"    </a>",
"    ]. Aortic root dilation was present in 43 and AR in 13 (25 percent). The AR was diagnosed at a mean age of 14.6 years (none before five years) and was initially mild in all but one patient. At a mean follow-up of 7.9 years, aortic abnormalities progressed in 13, requiring aortic surgery in 10 for aortic root dilation or dissection. There is further progression in adulthood [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/7\">",
"     7",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?20/3/20538?source=see_link\">",
"     \"Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    As noted above, AR can occur in association with VSD. One report described long-term follow-up (1946 to 1989) in 92 patients who had VSD and audible AR [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/8\">",
"     8",
"    </a>",
"    ]. Onset of AR occurred at a median age of 5.3 years. The aortic valve was bicuspid in 10 percent and tricuspid in the remainder. Surgery was performed in 72 patients, including VSD closure and valvuloplasty in 50, VSD closure and aortic valve replacement in 15, and VSD closure alone in seven.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     MONITORING",
"    </span>",
"    &nbsp;&mdash;&nbsp;Children with AR should be followed by a pediatric cardiologist at least yearly to monitor for the development of symptoms, increasing left ventricular dilation, or worsening left ventricular systolic function. More frequent evaluation is recommended in patients with moderate to severe AR or those in whom the rate of change in their regurgitation is unclear.",
"   </p>",
"   <p>",
"    The majority of children remain asymptomatic, even with severe AR. As a result, serial echocardiographic assessment, including measurement of ventricular dimensions, volumes, and function, is crucial in determining the timing of surgical repair. Surgery is recommended for patients with symptoms of heart failure, signs or symptoms of ischemia with exertion, or at the first indication of a decline in left ventricular function. As in aortic stenosis, endocarditis prophylaxis is recommended for patients with aortic regurgitation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Medical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Several published reports indicate that vasodilators may be beneficial in selected asymptomatic adults with chronic AR. Little information is available in children. Thus, treatment of this disorder in children is largely based upon experience in adults. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/14/14567?source=see_link\">",
"     \"Vasodilator therapy in severe chronic aortic regurgitation in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Summarized briefly, ACE inhibitors in adults slow progression of left ventricular dysfunction in some but not all patients [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/9-11\">",
"     9-11",
"    </a>",
"    ],",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/2/9256?source=see_link\">",
"     nifedipine",
"    </a>",
"    is more predictably effective [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/12,13\">",
"     12,13",
"    </a>",
"    ], and there are conflicting data on the efficacy of",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?4/53/4949?source=see_link\">",
"     hydralazine",
"    </a>",
"    &nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/9,14\">",
"     9,14",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    ACE inhibitors may be beneficial in children, with partial reversal of left ventricular dilation and hypertrophy. The possible benefit was illustrated in an uncontrolled series of 20 children (mean age 14.3 years) with asymptomatic chronic AR who were treated for one year [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/15\">",
"     15",
"    </a>",
"    ].",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?18/20/18760?source=see_link\">",
"     Captopril",
"    </a>",
"    therapy was associated with significant reductions in left ventricular end-diastolic and end-systolic dimensions, end-diastolic and end-systolic indexes, and left ventricular mass index. The regurgitant fraction was reduced by 28 percent.",
"   </p>",
"   <p>",
"    The main indications for vasodilator therapy in children with AR are any degree of AR more than mild, those who are symptomatic",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    have concurrent hypertension. ACE inhibitors such as",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?18/20/18760?source=see_link\">",
"     captopril",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/18/32040?source=see_link\">",
"     enalapril",
"    </a>",
"    are well tolerated in children and tend to be first-line therapy.",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?9/2/9256?source=see_link\">",
"     Nifedipine",
"    </a>",
"    or",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?4/53/4949?source=see_link\">",
"     hydralazine",
"    </a>",
"    are second-line agents. There is no published evidence to support the long-term use of vasodilators in asymptomatic patients with only mild to moderate AR and modest left ventricular enlargement.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Surgery",
"    </span>",
"    &nbsp;&mdash;&nbsp;Symptoms of heart failure, signs or symptoms of ischemia with exertion, or the first indication of a decline in left ventricular systolic function are indications for aortic valve repair or replacement. The choice between these procedures depends upon the cause of AR and the possible presence of other anatomic abnormalities.",
"   </p>",
"   <p>",
"    Valve repair is effective for AR caused by balloon dilation of congenital AS, and can be used for truncal valves or prolapse of one or more cusps associated with a VSD [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/8,16-18\">",
"     8,16-18",
"    </a>",
"    ]. In one report, 21 patients, age nine months to 15 years, had surgical repair of AR following balloon dilation of congenital AS [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/16\">",
"     16",
"    </a>",
"    ]. The extent of AR, left ventricular end-diastolic dimension, and proximal regurgitant",
"    <span class=\"nowrap\">",
"     jet/aortic",
"    </span>",
"    annulus diameter ratio were significantly decreased following repair. All patients survived and were asymptomatic at an average follow-up of 30 months. None required reoperation for late failure although 20 percent needed reintervention by three years.",
"   </p>",
"   <p>",
"    Aortic valve replacement usually requires a mechanical prosthesis and systemic anticoagulation. In one German study of 30 patients, which included 20 patients with AR, four with a combination of AR and stenosis, and six with aortic stenosis, aortic valve replacement using a mechanical prosthesis at a median age of 14.3 years resulted in normalization of left ventricular size and function in most patients at a median follow-up of six years [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/19\">",
"     19",
"    </a>",
"    ]. Bioprosthetic valves reduce the need for anticoagulation, but have a failure rate in children as high as 20 percent due to valve degeneration and progressive calcification [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/20,21\">",
"     20,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    An alternative to valve replacement with a mechanical valve or bioprosthesis is the Ross or",
"    <span class=\"nowrap\">",
"     Ross/Konno",
"    </span>",
"    procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/22-24\">",
"     22-24",
"    </a>",
"    ]. With this procedure, the pulmonary valve is transplanted to the aortic position, and a homograft conduit is implanted from the right ventricle to the pulmonary artery. Use of this technique has been limited by the high rates of failure of the pulmonary autograft and deterioration of the right heart homografts. A meta-analysis of published studies on the Ross procedure observed that compared to adults, children had a higher early mortality rate (4.2 versus 3.2 percent) and slightly higher rates of autograft deterioration (1.4 versus 0.8",
"    <span class=\"nowrap\">",
"     percent/patient-year),",
"    </span>",
"    and homograft deterioration (1.6 versus 0.6",
"    <span class=\"nowrap\">",
"     percent/patient-year)",
"    </span>",
"    [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/25\">",
"     25",
"    </a>",
"    ]. The higher rate of autograft deterioration in patients with predominantly aortic regurgitation, presumably due to progressive annular dilation, has led some to avoid the Ross procedure in this setting [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1559/abstract/25\">",
"     25",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31881?source=see_link\">",
"     \"Indications for valve replacement in aortic stenosis in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Aortic regurgitation (AR) is a common finding in children undergoing echocardiography. It rarely occurs as an isolated lesion, as it is usually associated with aortic stenosis (AS) or a ventricular septal defect (VSD).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      AR occurs when a portion of the left ventricular stroke volume leaks back from the aorta into the left ventricle because the aortic valve leaflets are unable to remain closed during diastole. AR causes an increase in left ventricular end-diastolic volume, resulting in left ventricular hypertrophy. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Physiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      AR is caused by many disorders, including bicuspid aortic valve; progressive aortic root dilation in patients with Marfan syndrome; or as a sequelae of rheumatic heart disease, infectious endocarditis, or valvuloplasty. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Etiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The physical examination varies depending upon the degree of AR. The classical findings of AR consist of wide pulse pressure, lateral and inferior displacement of a diffuse and hyperdynamic apical pulse, and the presence of a high-pitched diastolic murmur, which is often blowing in quality. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'Physical examination'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The diagnosis of AR is made by echocardiography. Serial echocardiographic assessments are used to guide management, including the need and timing of aortic valve surgery. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Most cases of AR are mild, asymptomatic, and remain stable over many years. Children with AR should be followed yearly by a pediatric cardiologist for the development of symptoms, increasing left ventricular dilation, or worsening left ventricular systolic function. More frequent evaluation is recommended in patients with moderate to severe AR or those in whom the rate of change in their regurgitation is unclear. (See",
"      <a class=\"local\" href=\"#H8\">",
"       'Monitoring'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Medical management consists of vasodilator therapy, which may slow the progression of left ventricular dysfunction. The main indications for vasodilator therapy in children with AR are any degree of AR more than mild, those who are symptomatic,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      have concurrent hypertension. Angiotensin inhibitors such as",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?18/20/18760?source=see_link\">",
"       captopril",
"      </a>",
"      and",
"      <a class=\"drug drug_pediatric\" href=\"UTD.htm?31/18/32040?source=see_link\">",
"       enalapril",
"      </a>",
"      are well tolerated in children and tend to be first-line therapy. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Medical therapy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The indications for surgical aortic repair or replacement include signs or symptoms of heart failure, ischemia with exertion, or decline in left ventricular systolic function. The choice between repair and replacement depends upon the cause of AR and the presence of other anatomic abnormalities. (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Surgery'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Latson LA. Aortic stenosis: valvar, supravalvar, and fibromuscular subvalvar. In: The Science and Practice of Pediatric Cardiology, Garson A, Bricker JT, Fisher DJ, Neish SR (Eds), Williams and Wilkins, Baltimore 1998. p.1257.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/2\">",
"      Donofrio MT, Engle MA, O'Loughlin JE, et al. Congenital aortic regurgitation: natural history and management. J Am Coll Cardiol 1992; 20:366.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/3\">",
"      Moore P, Egito E, Mowrey H, et al. Midterm results of balloon dilation of congenital aortic stenosis: predictors of success. J Am Coll Cardiol 1996; 27:1257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/4\">",
"      Choudhry NK, Etchells EE. The rational clinical examination. Does this patient have aortic regurgitation? JAMA 1999; 281:2231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/5\">",
"      Cheitlin MD. Finding 'just the right moment' for operative intervention in the asymptomatic patient with moderate to severe aortic regurgitation. Circulation 1998; 97:518.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/6\">",
"      van Karnebeek CD, Naeff MS, Mulder BJ, et al. Natural history of cardiovascular manifestations in Marfan syndrome. Arch Dis Child 2001; 84:129.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/7\">",
"      Bruno L, Tredici S, Mangiavacchi M, et al. Cardiac, skeletal, and ocular abnormalities in patients with Marfan's syndrome and in their relatives. Comparison with the cardiac abnormalities in patients with kyphoscoliosis. Br Heart J 1984; 51:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/8\">",
"      Rhodes LA, Keane JF, Keane JP, et al. Long follow-up (to 43 years) of ventricular septal defect with audible aortic regurgitation. Am J Cardiol 1990; 66:340.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/9\">",
"      Lin M, Chiang HT, Lin SL, et al. Vasodilator therapy in chronic asymptomatic aortic regurgitation: enalapril versus hydralazine therapy. J Am Coll Cardiol 1994; 24:1046.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/10\">",
"      Sch&ouml;n HR, Dorn R, Barthel P, Sch&ouml;mig A. Effects of 12 months quinapril therapy in asymptomatic patients with chronic aortic regurgitation. J Heart Valve Dis 1994; 3:500.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/11\">",
"      Wisenbaugh T, Sinovich V, Dullabh A, Sareli P. Six month pilot study of captopril for mildly symptomatic, severe isolated mitral and isolated aortic regurgitation. J Heart Valve Dis 1994; 3:197.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/12\">",
"      Scognamiglio R, Fasoli G, Ponchia A, Dalla-Volta S. Long-term nifedipine unloading therapy in asymptomatic patients with chronic severe aortic regurgitation. J Am Coll Cardiol 1990; 16:424.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/13\">",
"      Scognamiglio R, Rahimtoola SH, Fasoli G, et al. Nifedipine in asymptomatic patients with severe aortic regurgitation and normal left ventricular function. N Engl J Med 1994; 331:689.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/14\">",
"      Greenberg B, Massie B, Bristow JD, et al. Long-term vasodilator therapy of chronic aortic insufficiency. A randomized double-blinded, placebo-controlled clinical trial. Circulation 1988; 78:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/15\">",
"      Alehan D, Ozkutlu S. Beneficial effects of 1-year captopril therapy in children with chronic aortic regurgitation who have no symptoms. Am Heart J 1998; 135:598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/16\">",
"      Bacha EA, Satou GM, Moran AM, et al. Valve-sparing operation for balloon-induced aortic regurgitation in congenital aortic stenosis. J Thorac Cardiovasc Surg 2001; 122:162.",
"     </a>",
"    </li>",
"    <li>",
"     Keane JF, Fyler DC. Aortic outflow abnormalities. In: Nadas' Pediatric Cardiology, Keane JF, Lock JE, Fyler DC (Eds), Saunders/Elsevier, Philadelphia 2006. p.598.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/18\">",
"      Bacha EA, McElhinney DB, Guleserian KJ, et al. Surgical aortic valvuloplasty in children and adolescents with aortic regurgitation: acute and intermediate effects on aortic valve function and left ventricular dimensions. J Thorac Cardiovasc Surg 2008; 135:552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/19\">",
"      Arnold R, Ley-Zaporozhan J, Ley S, et al. Outcome after mechanical aortic valve replacement in children and young adults. Ann Thorac Surg 2008; 85:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/20\">",
"      Walker WE, Duncan JM, Frazier OH Jr, et al. Early experience with the ionescu-shiley pericardial xenograft valve. Accelerated calcification in children. J Thorac Cardiovasc Surg 1983; 86:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/21\">",
"      Kirklin JK, Smith D, Novick W, et al. Long-term function of cryopreserved aortic homografts. A ten-year study. J Thorac Cardiovasc Surg 1993; 106:154.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/22\">",
"      Ohye RG, Gomez CA, Ohye BJ, et al. The Ross/Konno procedure in neonates and infants: intermediate-term survival and autograft function. Ann Thorac Surg 2001; 72:823.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/23\">",
"      Laforest I, Dumesnil JG, Briand M, et al. Hemodynamic performance at rest and during exercise after aortic valve replacement: comparison of pulmonary autografts versus aortic homografts. Circulation 2002; 106:I57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/24\">",
"      Laudito A, Brook MM, Suleman S, et al. The Ross procedure in children and young adults: a word of caution. J Thorac Cardiovasc Surg 2001; 122:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1559/abstract/25\">",
"      Takkenberg JJ, Klieverik LM, Schoof PH, et al. The Ross procedure: a systematic review and meta-analysis. Circulation 2009; 119:222.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5778 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-115.124.72.62-8E1C3CC7B2-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1559=[""].join("\n");
var outline_f1_33_1559=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H12\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      PHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      ETIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PHYSICAL EXAMINATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Cardiac auscultation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      CLINICAL COURSE",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      MONITORING",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Medical therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Surgery",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PEDS/5778\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5778|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?37/25/38288\" title=\"figure 1\">",
"      Aortic regurgitation CW Doppler",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5778|MOV\">",
"      <a href=\"#\" title=\"MOVIES\">",
"       MOVIES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?0/12/195\" title=\"movie 1\">",
"      Aortic regurgitation as heard at the lower left sternal border",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?39/27/40368\" title=\"movie 2\">",
"      AR as heard at the second right intercostal space",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?41/61/42960\" title=\"movie 3\">",
"      Aortic regurgitation as heard at the apex",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?25/7/25716\" title=\"movie 4\">",
"      Apical 5 chamber echo with color Doppler AR",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_movie\" href=\"UTD.htm?8/2/8227\" title=\"movie 5\">",
"      TEE aortic regurgitation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"PEDS/5778|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/52/6989\" title=\"table 1\">",
"      ACC AHA diagnosis evaluation AR",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/37/26202?source=related_link\">",
"      Auscultation of cardiac murmurs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/56/22410?source=related_link\">",
"      Auscultation of heart sounds",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/15/33013?source=related_link\">",
"      Examination of the arterial pulse",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?20/3/20538?source=related_link\">",
"      Genetics, clinical features, and diagnosis of Marfan syndrome and related disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/8/31881?source=related_link\">",
"      Indications for valve replacement in aortic stenosis in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?8/19/8506?source=related_link\">",
"      Pathophysiology and clinical features of isolated ventricular septal defects in infants and children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/9/38039?source=related_link\">",
"      Pathophysiology, clinical features, and evaluation of chronic aortic regurgitation in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/28/38345?source=related_link\">",
"      Valvar aortic stenosis in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/14/14567?source=related_link\">",
"      Vasodilator therapy in severe chronic aortic regurgitation in adults",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_33_1560="ECG - ALCAPA";
var content_f1_33_1560=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F51869&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F51869&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 606px\">",
"   <div class=\"ttl\">",
"    Electrocardiogram in a 10-week-old infant with anomalous left coronary arising off the pulmonary artery (ALCAPA)",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 586px; height: 314px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram demonstrating deep q waves in inferior and lateral leads (I, aVL, and V5-V6) with ST segment and T wave abnormalities in a 10-week-old female with anomalous left coronary arising off the pulmonary artery (ALCAPA).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1560=[""].join("\n");
var outline_f1_33_1560=null;
var title_f1_33_1561="ECG pulmonary atresia with intact VS";
var content_f1_33_1561=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F88539&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F88539&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 630px\">",
"   <div class=\"ttl\">",
"    Electrocardiograph of an infant with pulmonary atresia with intact ventricular septum",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 610px; height: 358px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This electrocardiogram (ECG) of a neonate demonstrates several features consistent with pulmonary atresia with an intact ventricular septum (PA/IVS), including right atrial enlargement based on tall p waves in leads I, II, and aVF, and abnormal relative left axis deviation (QRS axis +30 degrees) due to a decrease of right-sided forces from RV hypoplasia. Cyanosis in a neonate with left axis deviation on ECG should prompt the clinician to consider PA/IVS. Although the ECG does not demonstrate significant myocardial ischemia, ST and T wave abnormalities should be ruled out on all patients with PA/IVS due to the possibility of coronary abnormalities.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1561=[""].join("\n");
var outline_f1_33_1561=null;
var title_f1_33_1562="Anal intraepithelial neoplasia: Diagnosis, screening, prevention, and treatment";
var content_f1_33_1562=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Anal intraepithelial neoplasia: Diagnosis, screening, prevention, and treatment",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/33/1562/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/33/1562/contributors\">",
"     Joel M Palefsky, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/33/1562/contributors\">",
"     Ross D Cranston, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/33/1562/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/33/1562/contributors\">",
"     Bruce J Dezube, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?1/33/1562/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?1/33/1562/contributors\">",
"     Michael E Ross, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?1/33/1562/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Mar 18, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anal and cervical canal share embryologic, histologic, and pathologic characteristics. Both develop from the embryonic cloacal membrane, and are sites of fusions of endodermal and ectodermal tissue to form a squamocolumnar epithelial junction. Both areas may display normal metaplastic change and abnormal dysplastic change related to infection with human papillomavirus (HPV) (",
"    <a class=\"graphic graphic_figure graphicRef82322 \" href=\"UTD.htm?33/43/34489\">",
"     figure 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26455?source=see_link\">",
"     \"Virology of human papillomavirus infections and the link to cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The biologic consequences of anal intraepithelial neoplasia (AIN), also termed anal squamous intraepithelial lesions (ASIL) and anal dysplasia, are considered analogous to those of cervical dysplasia. As with cervical intraepithelial neoplasia, AIN may be further subdivided into low-grade AIN and high-grade AIN. Anal high-grade AIN is considered premalignant and may progress to anal cancer, similar to the progression of cervical high-grade cervical intraepithelial neoplasia to cervical cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/1\">",
"     1",
"    </a>",
"    ]. Although low-grade AIN is not considered to be a direct precursor of anal cancer, it may progress to high-grade AIN. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28537?source=see_link\">",
"     \"Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The risk factors, pathology, clinical manifestations, screening, prevention, and treatment of AIN are discussed here. Anal cancer is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38762?source=see_link\">",
"     \"Clinical features, staging, and treatment of anal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     RISK FACTORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of risk factors have been identified in the development of AIN; these include anal HPV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/2,3\">",
"     2,3",
"    </a>",
"    ], receptive anal intercourse [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/4\">",
"     4",
"    </a>",
"    ], HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/2\">",
"     2",
"    </a>",
"    ], and lower CD4 levels [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     HPV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;HPV infection of the anal canal and perianal region may be latent, subclinical, or clinically apparent as condylomata. Latent infection occurs after acquisition of HPV but before any clinical evidence of infection. This period may last eight months or longer, and some individuals never develop clinically apparent lesions. Subclinical anal infections, such as the presence of high-grade AIN, may be identified by high-resolution anoscopy (HRA), a method of examining the anal canal that uses the application of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19011?source=see_link\">",
"     acetic acid",
"    </a>",
"    and magnification [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/5\">",
"     5",
"    </a>",
"    ]. Condylomata, when present, are usually clinically obvious and often have a frond-like or plaque-like appearance (",
"    <a class=\"graphic graphic_picture graphicRef55494 \" href=\"UTD.htm?17/24/17794\">",
"     picture 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23144?source=see_link\">",
"     \"Condylomata acuminata (anogenital warts)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prevalence of AIN correlates well with observed patterns of HPV infection, a causative factor for both AIN and anal cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/6-9\">",
"     6-9",
"    </a>",
"    ]. Using polymerase chain reaction (PCR) technology, one group has identified 29 individual HPV types and 10 HPV groups from the anal canal of men who have sex with men (MSM), both with and without HIV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/10\">",
"     10",
"    </a>",
"    ]. The spectrum of HPV types with both low-risk and high-risk phenotypes in the dysplastic anal canal is similar to that described in the dysplastic cervix. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26455?source=see_link\">",
"     \"Virology of human papillomavirus infections and the link to cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    These risk factors for AIN are consistent with the observed relationship between HPV infection and anal cancer. In certain populations, such as MSM and HIV-infected individuals, there is an especially high incidence of anal cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12761?source=see_link&amp;anchor=H7#H7\">",
"     \"Classification and epidemiology of anal cancer\", section on 'Epidemiology and risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Some individuals, particularly those who are HIV-positive, are more frequently infected with multiple HPV types [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/6,10\">",
"     6,10",
"    </a>",
"    ]. This has been associated with both the presence of prevalent AIN and also an increased risk of progression from low-grade AIN to high-grade AIN compared to infection with a single HPV type or absence of detectable infection [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H1116102\">",
"    <span class=\"h2\">",
"     High-risk sexual behavior",
"    </span>",
"    &nbsp;&mdash;&nbsp;The importance of high-risk behavior in men comes from an analysis of the prevalence of AIN in HIV-negative MSM. In a detailed study of 1262 MSM, AIN (detected by anal cytology) was present in 20 percent of the population (5 percent with high-grade AIN and 15 percent with LG-AIN) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/6\">",
"     6",
"    </a>",
"    ]. The age-related prevalence of AIN was analyzed in terms of underlying behavior patterns and infection with HPV. Using multivariate analysis, the factors significantly associated with the presence of AIN included anal HPV infection, the number and type of HPV present, and high-risk sexual behavior.",
"   </p>",
"   <p>",
"    The prevalence of anal HPV infection in MSM is high at all ages between 18 and &gt;50 years and ranges between 50 and 60 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/11\">",
"     11",
"    </a>",
"    ]. It has been suggested that HPV infection is transient and that individuals remain at risk for developing new HPV infections if high-risk behavior continues. The observation that there was no increase in HPV prevalence with increasing age in this population is consistent with this observation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/6\">",
"     6",
"    </a>",
"    ]. This is also consistent with the absence of immunity following initial infection. As expected, the presence of abnormal anal cytology in MSM does not vary with age [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/6\">",
"     6",
"    </a>",
"    ]. Both high HPV detection rates and abnormal cytology likely reflect the high number of new sexual partners in these urban MSM.",
"   </p>",
"   <p>",
"    In women, there are contrasting findings as HIV-negative women whose initial high cervical HPV detection rates and rates of cytological abnormality at younger age groups are not sustained over time. In women, risk factors for AIN include a history of receptive anal intercourse and presence of HPV DNA [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/12\">",
"     12",
"    </a>",
"    ]. Anal HPV infection appears to be at least as common as cervical HPV infection in HIV-positive women [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/13\">",
"     13",
"    </a>",
"    ]. Furthermore, HIV-positive women with abnormal cervical cytology have an increased risk of concurrent abnormal anal cytology [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     HIV infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;HIV infection is associated with an increased prevalence of HPV overall and with the most frequent oncogenic strains of HPV in MSMs. In a meta-analysis that included data from 53 studies, the prevalence of anal canal HPV of any type was statistically significant greater in HIV positive individuals compared with those who were HIV negative (93 versus 64 percent) and there was an increase in the prevalence of high risk HPV types as well (74 versus 37 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/14\">",
"     14",
"    </a>",
"    ]. Furthermore, HIV infection was associated with a statistically significant increased prevalence of AIN (57 versus 19 percent), including both low-grade AIN (28 versus 7 percent) and high grade AIN (6.7 versus 2.7 percent), as assessed by cytology.",
"   </p>",
"   <p>",
"    The increased prevalence of HPV infection and AIN may be due to multiple factors including a greater likelihood of high-risk sexual behavior and infection with multiple HPV types and an impaired mucosal immune response that facilitates HPV replication [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/6,10\">",
"     6,10",
"    </a>",
"    ]. Although lower baseline CD4 cell counts are a risk factor for high-grade AIN in MSM, high rates are found at all CD4 levels [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/15\">",
"     15",
"    </a>",
"    ]. In a study of 357 HIV-positive MSM, over 80 percent had anal dysplasia and 95 percent had HPV infection [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In the general population, anal cancer incidence, although increasing, is approximately 2 per 100,000. In contrast, the rate of anal cancer was estimated to be 35 per 100,000 among MSM prior to the HIV epidemic, similar to that of cervical cancer in women prior to the introduction of cervical Papanicolaou (Pap) smear screening. The current incidence of anal cancer among HIV-positive MSM has been estimated to be at least twice that of HIV-negative MSM. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12761?source=see_link\">",
"     \"Classification and epidemiology of anal cancer\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12761?source=see_link&amp;anchor=H10#H10\">",
"     \"Classification and epidemiology of anal cancer\", section on 'Human papillomavirus infection'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The widespread use of highly active antiretroviral therapy (HAART) has had a profound impact on reducing the incidence of HIV-associated malignancies such as Kaposi&rsquo;s sarcoma. However, HAART does not appear to alter the prevalence of AIN, and HAART may facilitate the progression of high-grade AIN to anal cancer due to its increasing life expectancy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Multivariate analysis that included length of HIV infection and viral load showed that the use of HAART and detection of &ge;6 HPV types were associated with the presence of AIN. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12761?source=see_link\">",
"     \"Classification and epidemiology of anal cancer\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    HIV infection is also a risk factor for AIN in women. This was illustrated in a study in which 251 HIV-positive and 68 high-risk HIV-negative women underwent clinical examination including anal cytology, anal HPV testing, and HRA [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/12\">",
"     12",
"    </a>",
"    ]. Compared with HIV-negative women, HIV-positive women had an increased risk of abnormal anal cytology (26 versus 8 percent) and high-grade AIN (6 versus 2 percent). Risk factors for AIN in this population included a lower CD4 cell count, a higher level of plasma HIV RNA, a history of receptive anal intercourse, and concurrent abnormal cervical cytology [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/19\">",
"     19",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Other risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Others risk factors that have been associated with the development of AIN in men include a history of rectal discharge [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/2\">",
"     2",
"    </a>",
"    ], history of genital warts [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/2\">",
"     2",
"    </a>",
"    ], injection drug use [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/20\">",
"     20",
"    </a>",
"    ], and current cigarette smoking [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/20\">",
"     20",
"    </a>",
"    ]. Additional risk factors in women include a history of cervical cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/21\">",
"     21",
"    </a>",
"    ], vulvar cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/22\">",
"     22",
"    </a>",
"    ], high-grade cervical intraepithelial neoplasia or vulvar intraepithelial neoplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/23\">",
"     23",
"    </a>",
"    ], and iatrogenic immunosuppression, such as following solid organ transplantation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/22,24\">",
"     22,24",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Risk factors for progression",
"    </span>",
"    &nbsp;&mdash;&nbsp;Risk factors for progression of anal low-grade AIN to high-grade AIN include HIV-related immunosuppression and the presence of multiple HPV types [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/10\">",
"     10",
"    </a>",
"    ]. In a study that included 346 HIV-positive and 262 HIV-negative MSM, the incidence of high-grade AIN within two years of enrollment was 20 percent in HIV-positive men and 8 percent in HIV-negative men with normal baseline examinations [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/15\">",
"     15",
"    </a>",
"    ]. In total, 62 percent of HIV-positive and 36 percent of HIV-negative men with low-grade AIN at baseline progressed to high-grade AIN.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h1\">",
"     PATHOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;AIN and the histopathologic manifestations of HPV infection are most apparent at the anal transition zone (ATZ) where rectal columnar epithelium and anal squamous epithelium meet (",
"    <a class=\"graphic graphic_figure graphicRef62539 \" href=\"UTD.htm?14/30/14819\">",
"     figure 2",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/1\">",
"     1",
"    </a>",
"    ]. AIN and cervical intraepithelial neoplasia share cytopathologic features, and both anal and cervical cytology are described using the 2001 Bethesda classification system (",
"    <a class=\"graphic graphic_table graphicRef71416 \" href=\"UTD.htm?18/51/19261\">",
"     table 1",
"    </a>",
"    ). Cytologic changes are reported, in increasing severity, as atypical squamous cells of undetermined significance (ASC-US), LG-AIN, and high-grade AIN [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/25\">",
"     25",
"    </a>",
"    ]. A diagnosis of atypical squamous cells cannot rule out the presence of a higher grade lesion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31065?source=see_link\">",
"     \"Cervical intraepithelial neoplasia: Definition, incidence, and pathogenesis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A biopsy diagnosis of high-grade AIN includes histologic grades AIN 2 and 3, and is diagnosed when abnormal basaloid cells, characterized by an increased nuclear to cytoplasmic ratio, replace more than one-half of the epithelium (",
"    <a class=\"graphic graphic_figure graphicRef82322 \" href=\"UTD.htm?33/43/34489\">",
"     figure 1",
"    </a>",
"    ). Low-grade AIN, corresponding to histologic grade AIN 1, is diagnosed when 20 to 25 percent of the epithelium is replaced by abnormal cells [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/26\">",
"     26",
"    </a>",
"    ]. AIN 1 is also characterized by the presence of koilocytes, enlarged cells with a cytoplasmic halo surrounding the nucleus that is indicative of active HPV replication.",
"   </p>",
"   <p>",
"    Lesions showing evidence of low-grade AIN may spontaneously regress, as is well documented in the cervix, or progress to high-grade AIN. Risk factors for progression of low-grade AIN to high-grade AIN in MSM include HIV infection, lower CD4+ level, anal HPV infection, and higher levels of deoxyribonucleic acid (DNA)",
"    <strong>",
"    </strong>",
"    of high-risk HPV types in the anal canal as described above [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/8,21,27,28\">",
"     8,21,27,28",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast, high-grade AIN rarely regresses, regardless of HIV status [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/15\">",
"     15",
"    </a>",
"    ]. Since high-grade AIN is considered to be the true",
"    <strong>",
"    </strong>",
"    precursor of invasive anal squamous cell carcinoma, ablative treatments should be considered, similar to the management of high-grade cervical intraepithelial neoplasia [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/8,28\">",
"     8,28",
"    </a>",
"    ]. In the cervix, regression and progression rates for each grade of cervical lesion have been characterized [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/29\">",
"     29",
"    </a>",
"    ]. However, as yet, relatively little is known of the long-term natural history of AIN, and studies are currently in progress to address this issue. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/15/40185?source=see_link\">",
"     \"Cervical cytology: Interpretation of results\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;AIN is mostly asymptomatic but may be associated with local symptoms such as pruritus, bleeding, discharge, irritation, and tenesmus. Diagnosis of AIN should begin with a comprehensive medical history and physical examination.",
"   </p>",
"   <p>",
"    Key areas in the medical history include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      History of clinical HPV infection and other sexually transmitted infections",
"     </li>",
"     <li>",
"      Sexual history including specific inquiry about receptive anal intercourse",
"     </li>",
"     <li>",
"      HIV serostatus and markers of infection (CD4+ level and viral load)",
"     </li>",
"     <li>",
"      Previous",
"      <span class=\"nowrap\">",
"       anal/gastrointestinal",
"      </span>",
"      conditions",
"     </li>",
"     <li>",
"      Local symptoms (pain, itch, bleeding, discharge, irritation, tenesmus)",
"     </li>",
"     <li>",
"      Smoking history",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The physical examination should include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Visual inspection of the perianal skin (",
"      <a class=\"graphic graphic_picture graphicRef65025 \" href=\"UTD.htm?34/10/34983\">",
"       picture 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Digital and high-resolution anoscopy examination of the anal canal. If anal cytology is planned, it should be performed before the digital or anoscopic examination and in the absence of lubricant.",
"     </li>",
"     <li>",
"      Examination of the inguinal lymph nodes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     SCREENING FOR AIN",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Rationale",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no randomized clinical trials that document the value of screening for AIN in an at-risk population [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/30\">",
"     30",
"    </a>",
"    ]. Instead, the rationale for screening relies upon the similarities between the anus and cervix, and the established success of cervical cytology screening in reducing the incidence of cervical cancer. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/32/35337?source=see_link\">",
"     \"Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    However, there is indirect evidence supporting the use of screening for AIN in high-risk populations that is derived from several sources [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/30\">",
"     30",
"    </a>",
"    ]. This includes the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The high incidence of anal cancer in the populations for which screening is proposed. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12761?source=see_link&amp;anchor=H7#H7\">",
"       \"Classification and epidemiology of anal cancer\", section on 'Epidemiology and risk factors'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The availability of screening modalities that can effectively diagnose the precursor lesion high-grade AIN. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Methodology'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      The availability of effective treatments that can ablate high-grade AIN. (See",
"      <a class=\"local\" href=\"#H17\">",
"       'Treatment'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      The significant morbidity and mortality associated with anal cancer if it is not prevented by effective screening and treatment. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38762?source=see_link\">",
"       \"Clinical features, staging, and treatment of anal cancer\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      The cost-effectiveness of screening. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Cost-effectiveness'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Who should be screened for AIN?",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although formal guidelines recommending anal screening for precancerous lesions have not been adopted by the United States Public Health Service, some specialists recommend anal cytologic screening for HIV-1-infected men and women [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The data for screening in other populations is much more limited. However, there is a scientific rationale for considering anal cytology screening in HIV-positive heterosexual men without a history of anal intercourse as one report showed a high prevalence of both anal HPV infection and AIN in such men [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/32\">",
"     32",
"    </a>",
"    ], individuals with perianal HPV lesions, HIV-positive women, women with high-grade",
"    <span class=\"nowrap\">",
"     vulval/vaginal",
"    </span>",
"    or cervical dysplasia, and solid organ transplant recipients who have an increased risk of anal cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/23,33\">",
"     23,33",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=see_link&amp;anchor=H8#H8\">",
"     \"Development of malignancy following solid organ transplantation\", section on 'Anogenital cancers'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Methodology",
"    </span>",
"    &nbsp;&mdash;&nbsp;The anal screening program relies upon cytology as the initial screening test in high-risk populations. The goal of screening is to identify individuals with abnormal cytology (ASC-US, ASC-H, low-grade AIN, high-grade AIN) who should then ideally undergo high-resolution anoscopy to assess the anal canal and map areas with visual markers consistent with high-grade AIN by biopsy and histopathologic evaluation. (See",
"    <a class=\"local\" href=\"#H8\">",
"     'Pathology'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h3\">",
"     Anal cytology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Anal exfoliative cytology should be performed using a water-moistened Dacron swab (Baxter Healthcare Corporation, McGraw Park, Illinois, USA) to collect cells prior to anoscopy or anal examination. Patients should be instructed to avoid anal sex, douching, and the use of enemas prior to this procedure, since these practices may decrease the cellular yield.",
"   </p>",
"   <p>",
"    The patient is positioned in the left lateral position, and the swab gently inserted until the swab cannot be advanced any further because it has reached the wall of the rectum, thus positioning the swab proximal to the anorectal transformation zone (squamocolumnar junction). The swab is then withdrawn with lateral pressure using a spiral motion to sample the entire circumference of the anal canal. Since the procedure is performed blindly, cells from the lower rectum, squamocolumnar transformation zone, and anal canal are sampled.",
"   </p>",
"   <p>",
"    After removal, the sample may be fixed either conventionally with ethanol or processed using the ThinPrep&trade; liquid cytology technique before staining with the Papanicolaou method. The latter method is preferable, when available, since it may yield better results among clinicians with limited experience in performing anal cytology [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/2\">",
"     2",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The sensitivity of anal cytology to detect biopsy-proven anal dysplasia in HIV-positive and HIV-negative MSM was 81 and 50 percent, respectively, when results from multiple screenings were considered and when ASC-US results were included in the &ldquo;abnormal&rdquo; category. This is similar to that the sensitivity of cervical cytology for the detection of cervical disease [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/34-36\">",
"     34-36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Self-collection of anal cytology samples appears to have similar sensitivity to that of clinician-collected samples, and may serve to increase patient compliance and decrease the cost of screening [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/37-39\">",
"     37-39",
"    </a>",
"    ]. This was illustrated by a series of 125 MSM, in which self-collected and clinician collected samples were compared with the results of high-resolution anoscopy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/39\">",
"     39",
"    </a>",
"    ]. Overall, 66 percent of the cohort was positive for HPV and 30 percent had biopsy-proven high-grade AIN. Among those who were HIV positive, the sensitivity of cytology to detect AIN was 75 and 90 percent, respectively, for self- and clinician-collected samples. Among those who were HIV negative, the sensitivities were 48 and 62 percent, respectively.",
"   </p>",
"   <p>",
"    Another cross-sectional study of HIV-negative MSM demonstrated adequate anal cytology in 92 percent of clinician-collected samples compared to 83 percent in self-collected samples (p&lt;0.001) with both groups using the same liquid cytology collection method at the same clinic visit [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/38\">",
"     38",
"    </a>",
"    ]. Most cytological diagnoses were of lower grade dysplasia such as ASC-US and low-grade AIN. However there were less frequent diagnoses of AIN than in the predominantly HIV-positive group (21 versus 33 to 39 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/37,38\">",
"     37,38",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other data suggest that anal cytology is an inaccurate predictor of the presence of high-grade AIN, regardless of HIV status. One series included 153 MSM (100 HIV-positive) who were referred to an anal dysplasia clinic because of abnormal screening anal cytology (n = 46), high-grade AIN on pathologic evaluation of surgically removed anogenital condylomata (n = 25), or a history of internal",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    external anal condylomata (n = 54) [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/40\">",
"     40",
"    </a>",
"    ]. When compared to the histologic findings, the sensitivity of anal cytology was only 47 percent for detection of a high-grade histological finding (AIN grade 2 or 3, or invasive squamous cell cancer). Moreover, a cytologic diagnosis of ASC-US (n = 30) showed a nearly equal distribution of histologic grade (with histology being normal, AIN 1, AIN 2, or AIN 3 in 11, 7, 5, and 7 participants, respectively). Thus, the presence of any abnormal anal cytologic finding indicates a potential for high-grade AIN on histologic examination.",
"   </p>",
"   <p>",
"    These results are consistent with those reported in an earlier larger series [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/35\">",
"     35",
"    </a>",
"    ]. Collectively, these data suggest that when high-grade AIN is found on anal cytology there is a high probability of high-grade disease on high-resolution anoscopy-guided biopsy. The finding of low-grade AIN or ASC-US on cytology, however, does not exclude the presence of high-grade AIN. For this reason, referral for high-resolution anoscopy should be considered for individuals with any cytologic abnormality.",
"   </p>",
"   <p>",
"    Alternatively, individuals considered to be at high risk for AIN, such as HIV-positive MSM, may be referred directly for high-resolution anoscopy and biopsy given the well-documented, high prevalence of AIN in these individuals.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h3\">",
"     High-resolution anoscopy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following the detection of abnormal anal cytology, the next step in the diagnostic evaluation is high-resolution anoscopy. This procedure allows the clinician to visualize lesions that represent the source of the abnormal cells and obtain biopsy specimens for histopathologic assessment. As in the cervix, anal histopathology is necessary to grade the severity of the disease, as this cannot be accurately established by visual evaluation or cytology alone.",
"   </p>",
"   <p>",
"    By wrapping a 4x4 gauze swab around a Q-tip, then soaking it in 3 percent",
"    <a class=\"drug drug_general\" href=\"UTD.htm?18/36/19011?source=see_link\">",
"     acetic acid",
"    </a>",
"    , the acid may be applied evenly to the anal canal prior to visualization. The acetic acid produces a white appearance in areas of abnormal transitional epithelium and facilitates mucosal examination for anoscopy as it does for cervical colposcopy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/41\">",
"     41",
"    </a>",
"    ]. Anoscopic changes most often associated with high-grade AIN are similar to those seen in cervical colposcopy [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/5\">",
"     5",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Cost-effectiveness",
"    </span>",
"    &nbsp;&mdash;&nbsp;Cost-effectiveness analyses suggest that periodic screening of both HIV-negative and HIV-positive MSM may be beneficial [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/42,43\">",
"     42,43",
"    </a>",
"    ]. In one study, a state&ndash;transition Markov model was developed to calculate lifetime costs, life expectancy, and quality-adjusted life expectancy for no screening versus several screening strategies in a population of HIV-positive MSM [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/43\">",
"     43",
"    </a>",
"    ]. Strategic variables in this model included screening interval and stage of HIV infection. Annual screening for AIN increased quality-adjusted life expectancy at all stages of HIV disease.",
"   </p>",
"   <p>",
"    Annual screening of HIV-positive MSM and screening every two to three years for HIV-negative MSM provided benefits in both life expectancy and cost effectiveness that were comparable to those achieved with the accepted use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?4/58/5034?source=see_link\">",
"     trimethoprim-sulfamethoxazole",
"    </a>",
"    for Pneumocystis jirovecii pneumonia prophylaxis in HIV disease. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33450?source=see_link\">",
"     \"Primary prevention of opportunistic infections in HIV-infected patients\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H445943593\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Vaccines directed against the HPV types associated with cervical and anal neoplasia in women and anal lesions in males have been developed. In a randomized trial in 4065 males, a quadrivalent vaccine was effective in preventing infection with HPV types 6, 11, 16, and 18 and prevented the development of external genital lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/44\">",
"     44",
"    </a>",
"    ]. The overall results of that trial are presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13480?source=see_link&amp;anchor=H19#H19\">",
"     \"Clinical trials of human papillomavirus vaccines\", section on 'Clinical trials of HPV vaccine in males'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A planned substudy of that trial analyzed the impact of HPV vaccine on the development of AIN in 602 MSM [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/45\">",
"     45",
"    </a>",
"    ]. The study population consisted of males aged 16 to 26 years who had a history of five or fewer lifetime sexual partners. Participants with a history or evidence of anal lesions were excluded, as were participants who were HIV positive at enrollment on the protocol. The primary endpoint of the trial was the development of AIN associated with HPV types 6, 11, 16, or 18.",
"   </p>",
"   <p>",
"    Two separate analyses were performed. The intent to treat analysis included all participants regardless of HPV positivity at baseline who received at least one dose of vaccine and had at least one follow-up visit. The analysis included all documented events after enrollment on the protocol. In a separate per protocol analysis, events were analyzed in patients who received all three doses of vaccine, and were HPV seronegative and had HPV DNA negative swab and biopsy specimens for the vaccine HPV types both at baseline and at month seven. In this analysis, only events that occurred after the completion of the vaccination sequence were counted.",
"   </p>",
"   <p>",
"    Overall, 598 patients received one or more doses of vaccine, and 551 of these were eligible for the intent to treat analysis. Key results included the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of AIN associated with HPV 6, 11, 16, or 18 was decreased by 50 percent in those receiving vaccine compared with placebo (6.3 versus 12.6 events per 100 person years at risk).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      There was a 50 percent decrease in the incidence of grade 1 AIN (low-grade) with vaccine (5.0 versus 9.9 events per 100 person years at risk).",
"     </li>",
"     <li>",
"      There was a 54 percent decrease in the incidence of grade 2 or 3 AIN (high grade) with vaccine (2.7 versus 6.0 events per 100 person years at risk). There were no cases of anal cancer in either group.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of persistent infection with the relevant HPV types was decreased by 59 percent (8.8 versus 21.6 events per 100 person years at risk), and the detection of HPV DNA was decreased by 49 percent (15.9 versus 30.9 events per 100 person years at risk).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The per protocol analysis included 402 of the 598 men (67 percent) who received all three doses of vaccine. Results included the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of AIN associated with HPV 6, 11, 16, or 18 was decreased by 78 percent in those receiving vaccine compared with placebo (1.3 versus 5.8 events per 100 person years at risk).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      There was a 73 percent decrease in the incidence of grade 1 AIN with vaccine (1.0 versus 3.9 events per 100 person years at risk).",
"     </li>",
"     <li>",
"      There was a 75 percent decrease in the incidence of grade 2 or 3 AIN with vaccine (0.8 versus 3.1 events per 100 person years at risk).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The incidence of persistent infection with the relevant HPV types was decreased by 95 percent (0.5 versus 10.2 events per 100 person years at risk), and the detection of HPV DNA was decreased by 84 percent (2.7 versus 16.7 events per 100 person years at risk).",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The results of this trial indicate that the use of the quadrivalent vaccine can decrease the incidence of AIN in MSM. Recommendations for the use of HPV vaccines are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/17/19738?source=see_link\">",
"     \"Recommendations for the use of human papillomavirus vaccines\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no formal guidelines for managing the results of anal screening cytology, and the following should be regarded as suggested practice. Treatment algorithms used by the authors have been summarized [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    At the University of California, San Francisco, and the University of Pittsburgh, we routinely recommend that individuals with anal high-grade AIN receive treatment. Treatment of low-grade AIN, including condyloma, is optional since these lesions do not directly progress to invasive cancer. However, patients with low-grade AIN may elect to have therapy for a variety of reasons including symptoms (burning, itching, and bleeding) or psychological distress. Patients with low-grade AIN who are not treated should be followed every six months because of the established high rate of progression to high-grade AIN. Prior to treatment, a thorough assessment should be performed to exclude anal cancer.",
"   </p>",
"   <p>",
"    There are few data on the efficacy of treatments for AIN, and those that exist are discussed below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Topical therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;For small lesions (&lt;1 cm",
"    <sup>",
"     2",
"    </sup>",
"    at the base), local application of bichloroacetic or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?7/39/7794?source=see_link\">",
"     trichloroacetic acid",
"    </a>",
"    (TCA) may be considered. Topical application of TCA is generally well tolerated, but can occasionally be painful. A study showed that multiple application (up to four times) topical therapy with 85 percent TCA was safe, well tolerated, and effective with an approximate 70 percent response rate and showed greatest efficacy among younger patients and those with two or fewer lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/47\">",
"     47",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Preliminary data suggest that a course of topical 5-",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    may also be effective [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/48\">",
"     48",
"    </a>",
"    ]. A 16-week course of self-administered twice weekly treatment resulted in a complete response in 18 and a partial response in eight (overall response rate 57 percent).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Immune modulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;A course of self-applied, intraanal",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/59/20406?source=see_link\">",
"     imiquimod",
"    </a>",
"    , an immune modulator, can result in pathological resolution of AIN in HIV positive MSM on HAART [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/49,50\">",
"     49,50",
"    </a>",
"    ]. This approach may be for patients with widespread, multifocal disease.",
"   </p>",
"   <p>",
"    In the largest reported series, 64 men with high-grade AIN were randomly assigned to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/59/20406?source=see_link\">",
"     imiquimod",
"    </a>",
"    or placebo, applied to the anal canal three times per week for four months. Of the 28 patients given imiquimod, four had complete resolution and eight had the high-grade AIN downgraded to low-grade AIN. Only one of 25 patients on placebo had resolution of the high-grade AIN. At a median follow-up of three years, 61 percent of patients had sustained absence of high-grade AIN.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Infrared coagulation",
"    </span>",
"    &nbsp;&mdash;&nbsp;For lesions that are too large for TCA, office-based infrared coagulation (IRC) can be used. This device is approved by the United States Food and Drug Administration (FDA) for the treatment of hemorrhoids and for anal warts. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/61/6105?source=see_link\">",
"     \"Treatment of hemorrhoids\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23144?source=see_link\">",
"     \"Condylomata acuminata (anogenital warts)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Treatment consists of the direct application of a 1.5 second pulse of irradiation in the infrared range to dysplastic anal epithelium, which results in tissue destruction to depth of approximately 1.5 mm. The coagulated tissue can then be debrided using Tischler biopsy forceps. Possible procedure-related complications include immediate and delayed bleeding and infection [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    IRC is not yet approved for treatment of AIN. Multiple studies have demonstrated the safety and efficacy, in both HIV positive and HIV negative individuals [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/52-57\">",
"     52-57",
"    </a>",
"    ]. A retrospective study from New York City with 68 HIV-infected men who underwent IRC for biopsy-proven anal high-grade AIN showed a response rate of 70 percent in the treated anal sector at an average of 1.5 years follow-up [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/52\">",
"     52",
"    </a>",
"    ]. For the 30 percent of men with recurrent disease, the mean time to recurrence of high-grade AIN was approximately nine months. There were no procedure-related complications.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Anoscopy-directed lesion ablation",
"    </span>",
"    &nbsp;&mdash;&nbsp;For lesions that are too large for office-based local therapy, high-resolution anoscopy can be used to visually define areas of involvement for electrocautery ablation [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/56\">",
"     56",
"    </a>",
"    ]. For patients with circumferential or very extensive lesions, this approach may require a staged approach using multiple procedures. The use of high-resolution anoscopy, rather than mapping biopsies, may minimize complications.",
"   </p>",
"   <p>",
"    The effectiveness and safety of this approach was illustrated by a retrospective review of the experience with 246 patients treated at the University of California San Francisco over a ten-year period [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/56\">",
"     56",
"    </a>",
"    ]. Overall, 200 patients (81 percent) were treated with a single procedure, although 57 percent of these did develop recurrent disease at an average of 19 months after the initial procedure. In 46 patients (19 percent), multiple staged treatments were required for complete lesion ablation. Significant complications were observed in only nine patients (including one with bleeding requiring reoperation, two with anal stenosis, and four with anal fissures).",
"   </p>",
"   <p>",
"    The high rate of local recurrence, even in patients initially thought to have been completely ablated with a single procedure, mandates careful surveillance following treatment [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/56\">",
"     56",
"    </a>",
"    ]. Nonetheless, most such recurrences can be successfully managed with office-based therapy. (See",
"    <a class=\"local\" href=\"#H24\">",
"     'Posttreatment surveillance'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Observation",
"    </span>",
"    &nbsp;&mdash;&nbsp;For some patients with extensive high-grade AIN, none of the currently available therapeutic options will likely result in complete clearance, even if a stepped (staged) procedure is used. Clinical judgment may dictate less aggressive management, with a \"watch and wait\" approach.",
"   </p>",
"   <p>",
"    If this approach is chosen, patients should be instructed to report any new anal symptoms that may suggest progression to invasive anal cancer (eg, bleeding, continuous pain, or the development of a mass), and they should be seen every three to four months for repeat high-resolution anoscopy. Patients in whom eradication of high-grade AIN is not complete require careful monitoring, since high-grade dysplastic lesions can progress to invasive cancer relatively rapidly [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/58\">",
"     58",
"    </a>",
"    ]. Routine follow-up evaluation increases the likelihood that if a cancer develops, it will be diagnosed at a very early stage, increasing the likelihood that curative treatment can be applied.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H380099268\">",
"    <span class=\"h2\">",
"     Choice of therapy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Only limited data are available comparing different treatment modalities in men with high-grade AIN. In the only randomized trial, 156 men were randomly assigned to",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/59/20406?source=see_link\">",
"     imiquimod",
"    </a>",
"    , topical",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    , or electrocautery. All grades of AIN were included; high grade AIN was present in 57 percent of cases. Patients with perianal AIN constituted 17 percent of the study population.",
"   </p>",
"   <p>",
"    Among the 148 patients actually treated (modified intent to treat), the complete response rates with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/59/20406?source=see_link\">",
"     imiquimod",
"    </a>",
"    ,",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    , and electrocautery were 24, 17, and 39 percent, respectively. Recurrences were common, and by 72 weeks after initial treatment the cumulative recurrence rates were 71, 58, and 68 percent, respectively.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Posttreatment surveillance",
"    </span>",
"    &nbsp;&mdash;&nbsp;Due to high rates of recurrence and evolving AIN, surveillance is required following initial treatment. Although the optimal schedule has not been established, our approach is to follow up in four to six months, including a rebiopsy of the treatment site if there is lesion persistence. Anal cytology may also be useful as an adjunctive test to confirm lesion clearance.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h1\">",
"     PERIANAL AIN AND CARCINOMA",
"    </span>",
"    &nbsp;&mdash;&nbsp;HPV related perianal disease presents much more frequently to clinicians than does internal AIN. Typically, the lesions are palpable and recognizable as warts. Standard therapeutic approaches for these condylomata are discussed elsewhere. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23144?source=see_link\">",
"     \"Condylomata acuminata (anogenital warts)\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    On the other hand, perianal dysplasia (Bowen's disease, squamous cell skin cancer in situ) is less well described and recognized. In 1912, Bowen first described the lesions that bear his name as chronic, red or hyperpigmented, well-defined scaly plaques [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/59\">",
"     59",
"    </a>",
"    ]. Histologic examination shows high-grade AIN without dermal invasion. Perianal high-grade AIN is less often associated with HPV than those involving the anal canal, and approximately 5 percent of these lesions progress to invasive squamous cell cancer [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/60\">",
"     60",
"    </a>",
"    ]. Other studies have confirmed the malignant potential of these lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/61-63\">",
"     61-63",
"    </a>",
"    ]. Treatment modalities for Bowen's disease include electrodessication and curettage, and excisional surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?1/33/1562/abstract/64\">",
"     64",
"    </a>",
"    ].",
"    <a class=\"drug drug_general\" href=\"UTD.htm?19/59/20406?source=see_link\">",
"     Imiquimod",
"    </a>",
"    or topical 5-",
"    <a class=\"drug drug_general\" href=\"UTD.htm?32/32/33280?source=see_link\">",
"     fluorouracil",
"    </a>",
"    cream may also be tried. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=see_link\">",
"     \"Treatment and prognosis of cutaneous squamous cell carcinoma\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    AIN of varying grades may occur in the perianal skin without classical Bowenoid appearances, and unfortunately there is a paucity of clinical literature describing the gross or anoscopic appearances of these lesions. There are no nationally recognized treatment guidelines for perianal dysplasia.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rates of anal cancer are increasing in the general population and are particularly high in HIV-positive men who have sex with men (MSM). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12761?source=see_link&amp;anchor=H7#H7\">",
"     \"Classification and epidemiology of anal cancer\", section on 'Epidemiology and risk factors'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The biologic consequences of anal dysplasia or anal intraepithelial neoplasia (AIN) are considered analogous to those of cervical intraepithelial neoplasia. Using cervical cancer as a model, it is biologically likely that anal high-grade AIN is the precursor of invasive anal cancer. Moreover, if the same rationale for cytologic screening in cervical cancer is applied to AIN, treating anal high-grade AIN may prevent malignant progression of this lesion. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?34/32/35337?source=see_link\">",
"     \"Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The rationale for a screening program for groups at high risk is limited by the lack of studies documenting that screening for and treating high-grade AIN reduces the incidence of anal cancer. Other factors limiting implementation of such a program include an inadequate number of clinicians who are trained in collecting anal cytology samples and performing high-resolution anoscopy, a reluctance of some clinicians to address the issue of AIN with their patients, and patients' feelings of embarrassment and fear of potential discomfort associated with the collection of anal specimens. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Screening for AIN'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    HPV vaccines can significantly decrease the incidence of infection with the HPV types associated with cervical and anal neoplasia. This decrease was associated with a decrease in the development of AIN in MSM in a population of young men with no more than five lifetime sexual partners. Recommendations for the use of HPV vaccines are discussed separately. (See",
"    <a class=\"local\" href=\"#H445943593\">",
"     'Prevention'",
"    </a>",
"    above and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/17/19738?source=see_link\">",
"     \"Recommendations for the use of human papillomavirus vaccines\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The availability of treatment modalities for high-grade AIN varies by geographic location and the presence of clinical expertise and familiarity with this disease. Although treatment with a variety of approaches may result in complete regression, recurrences are frequent and post-treatment surveillance is necessary. Whether patients elect to treat the high-grade lesion or undertake regular surveillance only, they should be aware of the symptoms most commonly associated with the development of anal cancer in order to allow an early diagnosis should anal cancer develop. (See",
"    <a class=\"local\" href=\"#H17\">",
"     'Treatment'",
"    </a>",
"    above.)",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/1\">",
"      Palefsky JM. Anal human papillomavirus infection and anal cancer in HIV-positive individuals: an emerging problem. AIDS 1994; 8:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/2\">",
"      Palefsky JM, Holly EA, Ralston ML, et al. Anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual and bisexual men: prevalence and risk factors. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:320.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/3\">",
"      Palefsky JM, Shiboski S, Moss A. Risk factors for anal human papillomavirus infection and anal cytologic abnormalities in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr 1994; 7:599.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/4\">",
"      Moscicki AB, Hills NK, Shiboski S, et al. Risk factors for abnormal anal cytology in young heterosexual women. Cancer Epidemiol Biomarkers Prev 1999; 8:173.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/5\">",
"      Jay N, Berry JM, Hogeboom CJ, et al. Colposcopic appearance of anal squamous intraepithelial lesions: relationship to histopathology. Dis Colon Rectum 1997; 40:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/6\">",
"      Chin-Hong PV, Vittinghoff E, Cranston RD, et al. Age-related prevalence of anal cancer precursors in homosexual men: the EXPLORE study. J Natl Cancer Inst 2005; 97:896.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/7\">",
"      Kiviat NB, Critchlow CW, Holmes KK, et al. Association of anal dysplasia and human papillomavirus with immunosuppression and HIV infection among homosexual men. AIDS 1993; 7:43.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/8\">",
"      Palefsky JM, Holly EA, Hogeboom CJ, et al. Virologic, immunologic, and clinical parameters in the incidence and progression of anal squamous intraepithelial lesions in HIV-positive and HIV-negative homosexual men. J Acquir Immune Defic Syndr Hum Retrovirol 1998; 17:314.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/9\">",
"      Palefsky JM. Anal squamous intraepithelial lesions in human immunodeficiency virus-positive men and women. Semin Oncol 2000; 27:471.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/10\">",
"      Palefsky JM, Holly EA, Ralston ML, Jay N. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 1998; 177:361.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/11\">",
"      Chin-Hong PV, Vittinghoff E, Cranston RD, et al. Age-Specific prevalence of anal human papillomavirus infection in HIV-negative sexually active men who have sex with men: the EXPLORE study. J Infect Dis 2004; 190:2070.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/12\">",
"      Holly EA, Ralston ML, Darragh TM, et al. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 2001; 93:843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/13\">",
"      Williams AB, Darragh TM, Vranizan K, et al. Anal and cervical human papillomavirus infection and risk of anal and cervical epithelial abnormalities in human immunodeficiency virus-infected women. Obstet Gynecol 1994; 83:205.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/14\">",
"      Machalek DA, Poynten M, Jin F, et al.. Anal human papillomavirus infection and assoicated neoplastic lesions in men who have sex with men: a systematic review and meta-analysis. Lancet Oncol 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/15\">",
"      Palefsky JM, Holly EA, Ralston ML, et al. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 1998; 12:495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/16\">",
"      Palefsky JM, Holly EA, Efirdc JT, et al. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 2005; 19:1407.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/17\">",
"      Bower M, Powles T, Newsom-Davis T, et al. HIV-associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome? J Acquir Immune Defic Syndr 2004; 37:1563.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/18\">",
"      Crum-Cianflone NF, Hullsiek KH, Marconi VC, et al. Anal cancers among HIV-infected persons: HAART is not slowing rising incidence. AIDS 2010; 24:535.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/19\">",
"      Hessol NA, Holly EA, Efird JT, et al. Anal intraepithelial neoplasia in a multisite study of HIV-infected and high-risk HIV-uninfected women. AIDS 2009; 23:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/20\">",
"      Palefsky JM, Holly EA, Ralston ML, et al. Anal cytological abnormalities and anal HPV infection in men with Centers for Disease Control group IV HIV disease. Genitourin Med 1997; 73:174.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/21\">",
"      Melbye M, Spr&oslash;gel P. Aetiological parallel between anal cancer and cervical cancer. Lancet 1991; 338:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/22\">",
"      Ogunbiyi OA, Scholefield JH, Raftery AT, et al. Prevalence of anal human papillomavirus infection and intraepithelial neoplasia in renal allograft recipients. Br J Surg 1994; 81:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/23\">",
"      Scholefield JH, Sonnex C, Talbot IC, et al. Anal and cervical intraepithelial neoplasia: possible parallel. Lancet 1989; 2:765.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/24\">",
"      Tramujas da Costa e Silva I, de Lima Ferreira LC, Santos Gimenez F, et al. High-resolution anoscopy in the diagnosis of anal cancer precursor lesions in renal graft recipients. Ann Surg Oncol 2008; 15:1470.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/25\">",
"      Solomon D, Davey D, Kurman R, et al. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA 2002; 287:2114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/26\">",
"      Palefsky JM, Holly EA. Molecular virology and epidemiology of human papillomavirus and cervical cancer. Cancer Epidemiol Biomarkers Prev 1995; 4:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/27\">",
"      Palefsky JM, Barrasso R. HPV infection and disease in men. Obstet Gynecol Clin North Am 1996; 23:895.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/28\">",
"      Palefsky JM. Cutaneous and genital HPV-associated lesions in HIV-infected patients. Clin Dermatol 1997; 15:439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/29\">",
"      Arends MJ, Buckley CH, Wells M. Aetiology, pathogenesis, and pathology of cervical neoplasia. J Clin Pathol 1998; 51:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/30\">",
"      Chiao EY, Giordano TP, Palefsky JM, et al. Screening HIV-infected individuals for anal cancer precursor lesions: a systematic review. Clin Infect Dis 2006; 43:223.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/31\">",
"      Benson CA, Kaplan JE, Masur H, et al. Treating opportunistic infections among HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association/Infectious Diseases Society of America. MMWR Recomm Rep 2004; 53:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/32\">",
"      Piketty C, Darragh TM, Da Costa M, et al. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 2003; 138:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/33\">",
"      Sillman FH, Sentovich S, Shaffer D. Ano-genital neoplasia in renal transplant patients. Ann Transplant 1997; 2:59.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/34\">",
"      Sonnex C, Scholefield JH, Kocjan G, et al. Anal human papillomavirus infection: a comparative study of cytology, colposcopy and DNA hybridisation as methods of detection. Genitourin Med 1991; 67:21.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/35\">",
"      Palefsky JM, Holly EA, Hogeboom CJ, et al. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 1997; 14:415.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/36\">",
"      Nathan M, Singh N, Garrett N, et al. Performance of anal cytology in a clinical setting when measured against histology and high-resolution anoscopy findings. AIDS 2010; 24:373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/37\">",
"      Cranston RD, Darragh TM, Holly EA, et al. Self-collected versus clinician-collected anal cytology specimens to diagnose anal intraepithelial neoplasia in HIV-positive men. J Acquir Immune Defic Syndr 2004; 36:915.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/38\">",
"      Lampinen TM, Miller ML, Chan K, et al. Randomized clinical evaluation of self-screening for anal cancer precursors in men who have sex with men. Cytojournal 2006; 3:4.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/39\">",
"      Chin-Hong PV, Berry JM, Cheng SC, et al. Comparison of patient- and clinician-collected anal cytology samples to screen for human papillomavirus-associated anal intraepithelial neoplasia in men who have sex with men. Ann Intern Med 2008; 149:300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/40\">",
"      Panther LA, Wagner K, Proper J, et al. High resolution anoscopy findings for men who have sex with men: inaccuracy of anal cytology as a predictor of histologic high-grade anal intraepithelial neoplasia and the impact of HIV serostatus. Clin Infect Dis 2004; 38:1490.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/41\">",
"      Palefsky JM, Gonzales J, Greenblatt RM, et al. Anal intraepithelial neoplasia and anal papillomavirus infection among homosexual males with group IV HIV disease. JAMA 1990; 263:2911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/42\">",
"      Goldie SJ, Kuntz KM, Weinstein MC, et al. Cost-effectiveness of screening for anal squamous intraepithelial lesions and anal cancer in human immunodeficiency virus-negative homosexual and bisexual men. Am J Med 2000; 108:634.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/43\">",
"      Goldie SJ, Kuntz KM, Weinstein MC, et al. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 1999; 281:1822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/44\">",
"      Giuliano AR, Palefsky JM, Goldstone S, et al. Efficacy of quadrivalent HPV vaccine against HPV Infection and disease in males. N Engl J Med 2011; 364:401.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/45\">",
"      Palefsky JM, Giuliano AR, Goldstone S, et al. HPV vaccine against anal HPV infection and anal intraepithelial neoplasia. N Engl J Med 2011; 365:1576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/46\">",
"      Chin-Hong PV, Palefsky JM. Natural history and clinical management of anal human papillomavirus disease in men and women infected with human immunodeficiency virus. Clin Infect Dis 2002; 35:1127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/47\">",
"      Singh JC, Kuohung V, Palefsky JM. Efficacy of trichloroacetic acid in the treatment of anal intraepithelial neoplasia in HIV-positive and HIV-negative men who have sex with men. J Acquir Immune Defic Syndr 2009; 52:474.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/48\">",
"      Richel O, Wieland U, de Vries HJ, et al. Topical 5-fluorouracil treatment of anal intraepithelial neoplasia in human immunodeficiency virus-positive men. Br J Dermatol 2010; 163:1301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/49\">",
"      Kreuter A, Potthoff A, Brockmeyer NH, et al. Imiquimod leads to a decrease of human papillomavirus DNA and to a sustained clearance of anal intraepithelial neoplasia in HIV-infected men. J Invest Dermatol 2008; 128:2078.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/50\">",
"      Fox PA, Nathan M, Francis N, et al. A double-blind, randomized controlled trial of the use of imiquimod cream for the treatment of anal canal high-grade anal intraepithelial neoplasia in HIV-positive MSM on HAART, with long-term follow-up data including the use of open-label imiquimod. AIDS 2010; 24:2331.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/51\">",
"      Halasz CL. Treatment of common warts using the infrared coagulator. J Dermatol Surg Oncol 1994; 20:252.",
"     </a>",
"    </li>",
"    <li>",
"     Goldstone S, personal communication.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/53\">",
"      Stier EA, Goldstone SE, Berry JM, et al. Infrared coagulator treatment of high-grade anal dysplasia in HIV-infected individuals: an AIDS malignancy consortium pilot study. J Acquir Immune Defic Syndr 2008; 47:56.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/54\">",
"      Goldstone SE, Hundert JS, Huyett JW. Infrared coagulator ablation of high-grade anal squamous intraepithelial lesions in HIV-negative males who have sex with males. Dis Colon Rectum 2007; 50:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/55\">",
"      Cranston RD, Hirschowitz SL, Cortina G, Moe AA. A retrospective clinical study of the treatment of high-grade anal dysplasia by infrared coagulation in a population of HIV-positive men who have sex with men. Int J STD AIDS 2008; 19:118.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/56\">",
"      Pineda CE, Berry JM, Jay N, et al. High-resolution anoscopy targeted surgical destruction of anal high-grade squamous intraepithelial lesions: a ten-year experience. Dis Colon Rectum 2008; 51:829.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/57\">",
"      Weis SE, Vecino I, Pogoda JM, Susa JS. Treatment of high-grade anal intraepithelial neoplasia with infrared coagulation in a primary care population of HIV-infected men and women. Dis Colon Rectum 2012; 55:1236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/58\">",
"      Kreuter A, Potthoff A, Brockmeyer NH, et al. Anal carcinoma in human immunodeficiency virus-positive men: results of a prospective study from Germany. Br J Dermatol 2010; 162:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/59\">",
"      Bowen JT. Centennial paper. May 1912 (J Cutan Dis Syph 1912;30:241-255). Precancerous dermatoses: a study of two cases of chronic atypical epithelial proliferation. By John T. Bowen, M.D., Boston. Arch Dermatol 1983; 119:243.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/60\">",
"      Frisch M, Fenger C, van den Brule AJ, et al. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res 1999; 59:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/61\">",
"      Fenger C, Nielsen VT. Precancerous changes in the anal canal epithelium in resection specimens. Acta Pathol Microbiol Immunol Scand A 1986; 94:63.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/62\">",
"      Marfing TE, Abel ME, Gallagher DM. Perianal Bowen's disease and associated malignancies. Results of a survey. Dis Colon Rectum 1987; 30:782.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/63\">",
"      Jaeger AB, Gramkow A, Hjalgrim H, et al. Bowen disease and risk of subsequent malignant neoplasms: a population-based cohort study of 1147 patients. Arch Dermatol 1999; 135:790.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?1/33/1562/abstract/64\">",
"      Cleary RK, Schaldenbrand JD, Fowler JJ, et al. Perianal Bowen's disease and anal intraepithelial neoplasia: review of the literature. Dis Colon Rectum 1999; 42:945.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 8032 Version 14.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1002-61.234.146.186-8377BC303A-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1562=[""].join("\n");
var outline_f1_33_1562=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H26\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      RISK FACTORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      HPV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H1116102\">",
"      High-risk sexual behavior",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      HIV infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Other risk factors",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Risk factors for progression",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      PATHOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      SCREENING FOR AIN",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Rationale",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Who should be screened for AIN?",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Methodology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      - Anal cytology",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      - High-resolution anoscopy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Cost-effectiveness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H445943593\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Topical therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Immune modulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Infrared coagulation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Anoscopy-directed lesion ablation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Observation",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H380099268\">",
"      Choice of therapy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Posttreatment surveillance",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      PERIANAL AIN AND CARCINOMA",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"ONC/8032\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/8032|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?33/43/34489\" title=\"figure 1\">",
"      Squamous intraepithelial lesions",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/30/14819\" title=\"figure 2\">",
"      Anatomy of the anus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/8032|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?17/24/17794\" title=\"picture 1\">",
"      Anal condyloma",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?34/10/34983\" title=\"picture 2\">",
"      Anal squamous intraep neoplasia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"ONC/8032|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?18/51/19261\" title=\"table 1\">",
"      Bethesda class cervix cytol",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/32/35337?source=related_link\">",
"      Cervical cancer screening tests: Techniques and test characteristics of cervical cytology and human papillomavirus testing",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/15/40185?source=related_link\">",
"      Cervical cytology: Interpretation of results",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/21/31065?source=related_link\">",
"      Cervical intraepithelial neoplasia: Definition, incidence, and pathogenesis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?12/29/12761?source=related_link\">",
"      Classification and epidemiology of anal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?37/54/38762?source=related_link\">",
"      Clinical features, staging, and treatment of anal cancer",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/10/13480?source=related_link\">",
"      Clinical trials of human papillomavirus vaccines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?22/38/23144?source=related_link\">",
"      Condylomata acuminata (anogenital warts)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/23/34170?source=related_link\">",
"      Development of malignancy following solid organ transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/55/28537?source=related_link\">",
"      Invasive cervical cancer: Epidemiology, risk factors, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/42/33450?source=related_link\">",
"      Primary prevention of opportunistic infections in HIV-infected patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/17/19738?source=related_link\">",
"      Recommendations for the use of human papillomavirus vaccines",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/30/31209?source=related_link\">",
"      Treatment and prognosis of cutaneous squamous cell carcinoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/61/6105?source=related_link\">",
"      Treatment of hemorrhoids",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/53/26455?source=related_link\">",
"      Virology of human papillomavirus infections and the link to cancer",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f1_33_1563="Preventing lead exposure from soil";
var content_f1_33_1563=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F82132&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F82132&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Educational interventions to prevent exposure to lead in soil",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td>",
"        Cover bare soil with grass, plants, gravel, or wood chips",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Do not let children play near walls of house or garage on bare soil",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Have children play in grassy area or sandbox that can be covered",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Wash children's hands after playing outside, or playing with pets",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Remove shoes before entering the house",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Use a doormat to reduce track-in of outdoor dust and soil",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Environmental Protection Agency. (file://www.epa.gov/lead/educationexesum.htm).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1563=[""].join("\n");
var outline_f1_33_1563=null;
var title_f1_33_1564="Thymic carcinoma classification";
var content_f1_33_1564=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F73211&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F73211&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=6\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Classification of thymic carcinoma",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Suster &amp; Rosai (Cancer 1991; 67:1025).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Low-grade histology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Well differentiated squamous cell carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Basaloid carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Well differentiated mucoepidermoid carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        High-grade histology",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Lymphoepithelioma-like carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Small cell neuro-endocrine carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Undifferentiated/anaplastic carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Clear cell carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Sarcomatoid carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        WHO, Rosai, J. (Histological Typing of Tumors of the Thymus, 2nd ed, Springer, Berlin, 1999).",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epidermoid keratinizing (squamous cell) carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Epidermoid non-keratinizing carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lymphoepithelioma-like carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sarcomatoid carcinoma (Carcinosarcoma)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Clear cell carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Basaloid carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mucoepidermoid carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Papillary carcinoma",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Undifferentiated carcinoma",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1564=[""].join("\n");
var outline_f1_33_1564=null;
var title_f1_33_1565="IPD incidence and mortality";
var content_f1_33_1565=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F88701&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F88701&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Incidence and mortality rates of invasive pneumococcal disease in the United States, 2010  &mdash; Active Bacterial Core Surveillance (ABCs) report, Emerging Infections Program Network",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"5\" width=\"20%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Age (years)",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Cases",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Deaths",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        No.",
"       </td>",
"       <td class=\"subtitle2\">",
"        (Rate*)",
"       </td>",
"       <td class=\"subtitle2\">",
"        No.",
"       </td>",
"       <td class=\"subtitle2\">",
"        (Rate*)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &lt;1",
"       </td>",
"       <td class=\"centered\">",
"        142",
"       </td>",
"       <td class=\"centered\">",
"        (34.2)",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        (0.24)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        112",
"       </td>",
"       <td class=\"centered\">",
"        (26.6)",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        (0.24)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2-4",
"       </td>",
"       <td class=\"centered\">",
"        171",
"       </td>",
"       <td class=\"centered\">",
"        (13.1)",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        (0.08)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5-17",
"       </td>",
"       <td class=\"centered\">",
"        111",
"       </td>",
"       <td class=\"centered\">",
"        (2.2)",
"       </td>",
"       <td class=\"centered\">",
"        1",
"       </td>",
"       <td class=\"centered\">",
"        (0.02)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        18-34",
"       </td>",
"       <td class=\"centered\">",
"        260",
"       </td>",
"       <td class=\"centered\">",
"        (3.8)",
"       </td>",
"       <td class=\"centered\">",
"        18",
"       </td>",
"       <td class=\"centered\">",
"        (0.26)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        35-49",
"       </td>",
"       <td class=\"centered\">",
"        670",
"       </td>",
"       <td class=\"centered\">",
"        (10.5)",
"       </td>",
"       <td class=\"centered\">",
"        43",
"       </td>",
"       <td class=\"centered\">",
"        (0.68)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        50-64",
"       </td>",
"       <td class=\"centered\">",
"        1064",
"       </td>",
"       <td class=\"centered\">",
"        (18.8)",
"       </td>",
"       <td class=\"centered\">",
"        103",
"       </td>",
"       <td class=\"centered\">",
"        (1.82)",
"       </td>",
"      </tr>",
"      <tr class=\"divider_bottom\">",
"       <td>",
"        &ge;65",
"       </td>",
"       <td class=\"centered\">",
"        1292",
"       </td>",
"       <td class=\"centered\">",
"        (36.4)",
"       </td>",
"       <td class=\"centered\">",
"        199",
"       </td>",
"       <td class=\"centered\">",
"        (5.61)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Total:",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        <strong>",
"         3822",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        <strong>",
"         (12.8)",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        <strong>",
"         367",
"        </strong>",
"       </td>",
"       <td class=\"centered\">",
"        <strong>",
"         (1.23)",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     * Cases or deaths per 100,000 population for ABCs areas, which represent nearly 30,000,000 persons in certain counties in 10 states in the United States.",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced from: Centers for Disease Control and Prevention. Active Bacterial Core Surveillance (ABCs) report, Emerging Infections Program Network Streptococcus pneumoniae, 2010. Available at:",
"     <a href=\"file://www.cdc.gov/abcs/reports-findings/survreports/spneu10-orig.pdf\" style=\"font-style: italic;\" target=\"_blank\">",
"      file://www.cdc.gov/abcs/reports-findings/survreports/spneu10-orig.pdf",
"     </a>",
"     (Accessed March 21, 2013).",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1565=[""].join("\n");
var outline_f1_33_1565=null;
var title_f1_33_1566="Pruritus topical therapy";
var content_f1_33_1566=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F50432%7EDERM%2F63221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F50432%7EDERM%2F63221&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Topical therapies for pruritus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Medication",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose",
"       </td>",
"       <td class=\"subtitle1\">",
"        Notes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Barrier repair creams/moisturizers/emollients",
"       </td>",
"       <td>",
"        Not applicable",
"       </td>",
"       <td>",
"        Low pH products may be particularly useful",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Topical corticosteroids",
"       </td>",
"       <td>",
"        Variable",
"       </td>",
"       <td>",
"        Not directly antipruritic, may be useful in pruritus due to inflammatory skin dermatoses",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        Topical calcineurin inhibitors",
"       </td>",
"       <td>",
"        Tacrolimus 0.03% and 0.1% ointment",
"       </td>",
"       <td rowspan=\"2\">",
"        Particularly useful in anogenital pruritus, may experience transient burning and stinging",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pimecrolimus 1% cream",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Doxepin",
"       </td>",
"       <td>",
"        5% cream",
"       </td>",
"       <td>",
"        Avoid in children, 20 to 25 percent risk of sedation",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Menthol",
"       </td>",
"       <td>",
"        1 to 3% cream or lotion",
"       </td>",
"       <td>",
"        Useful in patients who report cooling as an alleviating factor",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Capsaicin",
"       </td>",
"       <td>",
"        0.025 to 0.1% cream",
"       </td>",
"       <td>",
"        Particularly useful in neuropathic itch, may experience initial transient burning",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        Salicylic acid",
"       </td>",
"       <td>",
"        2 to 6%",
"       </td>",
"       <td>",
"        Useful in lichen simplex chronicus, avoid in acute inflammatory dermatoses and children",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"4\">",
"        Local anesthetics",
"       </td>",
"       <td>",
"        Pramoxine 1 to 2.5%",
"       </td>",
"       <td>",
"        Useful for pruritus on face and that associated with CKD",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Lidocaine patch 5%",
"       </td>",
"       <td>",
"        Useful in neuropathic pruritus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Eutectic mixture of lidocaine 2.5% and prilocaine 2.5%",
"       </td>",
"       <td>",
"        Useful in neuropathic pruritus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        5% urea + 3% polidocanol",
"       </td>",
"       <td>",
"        Both moisturizing and anesthetic properties, not available in the United States",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CKD: chronic kidney disease; %: percent.",
"    </div>",
"    <div class=\"reference\">",
"     Patel T, Yosipovitch G. Therapy of pruritus. Expert Opin Pharmacother 2010; 11:1673. Copyright &copy; 2010 Informa Healthcare. Reproduced with permission of Informa Healthcare.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Systemic therapies for pruritus",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Medication*",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose range",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td class=\"subtitle1\">",
"        Notes",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Antihistamines",
"        </strong>",
"       </td>",
"       <td>",
"        Variable depending on medication",
"       </td>",
"       <td>",
"        No direct effect on pruritus except in urticaria; sedating antihistamines may be useful through their soporific effects",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td class=\"subtitle2_left\" colspan=\"3\">",
"        Antidepressants",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        SNRIs",
"       </td>",
"       <td>",
"        Mirtazapine 7.5 to 15 mg at night",
"       </td>",
"       <td>",
"        Useful in nocturnal pruritus, may cause increased weight and appetite",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"3\">",
"        SSRIs",
"       </td>",
"       <td>",
"        Paroxetine 10 to 40 mg per day",
"       </td>",
"       <td>",
"        Consider in psychiatric patients with pruritus and paraneoplastic pruritus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fluvoxamine 25 to 150 mg per day",
"       </td>",
"       <td>",
"        Consider in psychiatric patients with pruritus and paraneoplastic pruritus",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Sertraline 75 to 100 mg per day",
"       </td>",
"       <td>",
"        Useful in cholestatic pruritus",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         &micro;-opioid receptor antagonists",
"        </strong>",
"       </td>",
"       <td>",
"        Naltrexone 25 to 50 mg per day",
"       </td>",
"       <td>",
"        Useful in patients with cholestatic and CKD-associated pruritus; may cause nausea, vomiting and drowsiness; reverses analgesia and may precipitate acute withdrawal in patients receiving opioid analgesics",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         &kappa;-opioid receptor agonist/&micro;-opioid receptor antagonist",
"        </strong>",
"       </td>",
"       <td>",
"        Butorphanol 1 to 4 mg intranasally per day",
"       </td>",
"       <td>",
"        Useful in nocturnal and intractable pruritus; may cause nausea and vomiting as well as drowsiness; may precipitate acute withdrawal in patients receiving opioid analgesics; some potential for abuse due to concomitant weak &micro;-opioid receptor agonist activity",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Selective &kappa;-opioid receptor agonist",
"        </strong>",
"       </td>",
"       <td>",
"        Nalfurafine 2.5 to 5 micrograms per day",
"       </td>",
"       <td>",
"        Useful in CKD-associated pruritus; may cause insomnia; approved in Japan only",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td rowspan=\"2\">",
"        <strong>",
"         Anticonvulsants",
"        </strong>",
"       </td>",
"       <td>",
"        Gabapentin 100 to 3600 mg per day",
"       </td>",
"       <td rowspan=\"2\">",
"        Applies to both: useful in neuropathic pruritus, may cause drowsiness and weight gain; usually given in two to three divided daily doses; dose alteration for renal insufficiency may be needed",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Pregabalin 150 to 300 mg per day",
"       </td>",
"      </tr>",
"      <tr class=\"divider_top\">",
"       <td>",
"        <strong>",
"         Substance P antagonist",
"        </strong>",
"       </td>",
"       <td>",
"        Aprepitant 80 mg per day",
"       </td>",
"       <td>",
"        Beneficial in pruritus associated with the S&eacute;zary syndrome; expensive",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     CKD: chronic kidney disease; SNRI: selective neuroepinephrine reuptake inhibitor; SSRI: selective serotonin reuptake inhibitor.",
"     <br>",
"      * Immunosuppressive agents such as cyclosporine, azathioprine, and mycophenolate mofetil may be beneficial for pruritus in severe atopic dermatitis (see \"Management of severe refractory atopic dermatitis\").",
"      <br>",
"       <font class=\"bullet\">",
"        &bull;",
"       </font>",
"       All doses are for adult patients, oral administration, unless noted otherwise.",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     From: Patel T, Yosipovitch G. Therapy of pruritus. Expert Opin Pharmacother 2010; 11:1673. Copyright &copy; 2010 Informa Healthcare. Adapted with permission of Informa Healthcare.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1566=[""].join("\n");
var outline_f1_33_1566=null;
var title_f1_33_1567="Stem cell properties";
var content_f1_33_1567=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=HEME%2F77910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=HEME%2F77910&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 545px\">",
"   <div class=\"ttl\">",
"    Stem cell properties",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 525px; height: 302px; background-image: url(data:image/gif;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Schematic view of some general properties and assays for the heterogeneous cells that compromise the stem cell and progenitor cell compartments. As indicated, cells capable of permanently reconstituting in vivo hematopoiesis are separable from cells that give rise to day 12 CFU-S, but the precise developmental stage of in vitro long-term culture initiating cells (LTC- IC), cobblestone area forming cells (CAFC), CFU-blast and high proliferative potential colony forming cells (HPP-CFC) is not established. In the progenitor compartment, mixed colonies of almost all lineage combinations have been described.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f1_33_1567=[""].join("\n");
var outline_f1_33_1567=null;
